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Abstract 
Autophagy, an evolutionarily-conserved cellular process through which 
organelles and macromolecules are degraded in the lysosome, is induced under nutrient 
starvation or other unfavorable growth conditions.  Unc51-like kinase 1 (ULK1) is a 
serine/threonine protein kinase that plays a key role in the autophagy induction process, 
but how ULK1 is regulated by cellular signals for induction of autophagy and how ULK1 
regulates the downstream processes in autophagy remain poorly understood. ULK1 
interacts with Atg13, focal adhesion kinase family interacting protein of 200 kD (FIP200) 
and Atg101 to form a large protein complex involved in early steps of the autophagy 
induction process. To better understand the function of the ULK1 complex, my thesis 
work has sought to identify binding proteins of the complex.  Through a yeast two hybrid 
screen using a human fetal brain cDNA library with Atg13 as bait, a protein named 
MCF.2 cell line derived transforming sequence-like 2 (MCF2L2) was identified. Through 
co-immunoprecipitation and in vitro binding assay, MCF2L2 was determined to directly 
interact with Atg13 via its N-terminal region independently of ULK1. Knockdown of 
MCF2L2 inhibited the formation of autophagosome and autophagy flux and led to 
accumulation of p62/sequestosome-1, a protein degraded through autophagy. Knockdown 
of MCF2L2 also suppressed the aggregation of WD-repeat protein interacting with 
phosphoinositides-1, an autophagic isolation membrane marker. MCF2L2 contains a 
putative Rho-guanine nucleotide exchange factor (GEF) domain in the middle and has a 
sequence similarity to MCF2L and MCF2, the well-known Rho-GEFs. MCF2L2 
overexpression induced a moderate increase in the active forms of Rho GTPases and 
MCF2L2 colocalized with actin related protein 3, the actin nucleation factor that is 
regulated by Rho GTPases, implying that MCF2L2 potentially contains GEF activity. 
MCF2L2 knockdown partially suppressed the distribution of Atg9 from trans-golgi 
network to the cytoplasm in response to starvation, a process that may depend on  actin 
cytoskeleton. Combined, these results suggest that MCF2L2, as a component of the 
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ULK1 complex, might play an important role in mediating signal transduction between 
the actin cytoskeleton and autophagy induction. 
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CHAPTER 1. BACKGROUND 
This background section will discuss the protein components and protein 
complexes that are involved in the autophagy processes and how they function in the 
pathway.   Several key protein complexes, including the unc51 like kinase 1 (ULK1) 
complex and the Beclin 1 complexes, will be discussed with respect to their compositions 
and functions.  This section will also summarize the current knowledge about the cellular 
and physiological functions of autophagy.  The role of ULK1 complex in autophagy will 
be reviewed and at the end, I will discuss about the missing gaps in our knowledge about 
the autophagy processes and how I have shaped my thesis work based on the missing 
gaps. 
 
I.         The autophagy machinery 
Autophagy is a catabolic process evolutionarily conserved in eukaryotes through 
which cytoplasmic contents are delivered to the lysosome for degradation. There are four 
major types of autophagy; chaperone-mediated autophagy (CMA), microautophagy, 
macroautophagy and selective autophagy (Mizushima, 2009) (Figure 1).  CMA is 
mediated by chaperone proteins that recruit target substrates to receptors on the lysosome 
for subsequent unfolding and degradation (Li et al., 2011a).  Microautophagy is a 
membrane process of invagination, protrusion or separation of the lysosomal membrane 
through which cytoplasmic materials are engulfed directly by the lysosome (Li et al., 
2011b). Macroautophagy is a lysosomal degradation of cytoplasmic components or 
compartments captured in a double membrane structure (Eskelinen, 2005; Xie and 
Klionsky, 2007).  The double-membrane vesicular structure called autophagosome is the 
hallmark developed in the beginning of macroautophagy. While macroautophagy is 
considered a process of random engulfment of cytoplasmic components, an autophagic 
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process through which damaged organelles or extrinsic pathogens are selectively 
recognized and degraded in the lysosomes has been identified and called selective 
autophagy (Narendra et al., 2008; Thurston et al., 2009). Depending on what contents are 
recognized and degraded, selective autophagy is further divided into several types. For 
example, the selective autophagy process to eliminate damaged mitochondria is called 
mitophagy (Geisler et al., 2010; Kanki et al., 2009; Narendra et al., 2008). The processes 
to eliminate peroxisome (Iwata et al., 2006; Kim et al., 2008), mature ribosome (Kraft et 
al., 2008), endoplasmic reticulum (ER) (Bernales et al., 2006), or invading pathogens 
(Thurston et al., 2009; Yoshikawa et al., 2009; Zheng et al., 2009b) are called pexophagy, 
ribophagey, reticulophagy, or xenophagy, respectively.  Although the selective autophagy 
depends on adaptor molecules in recognition of target organelles and macromolecules, 
the process shares many components with macroautophagy for the degradation steps 
(reviewed in (Weidberg et al., 2011)). 
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Figure 1. Depiction of major forms of autophagy.   
The major forms of autophagy are illustrated. Counterclockwise from bottom 
right: Microautophagy is a process where cytoplasmic materials are engulfed directly into 
the lysosome (Li et al., 2011b).  CMA is mediated by chaperone proteins that recruit 
substrate proteins to receptors on the lysosome for unfolding and degradation (Li et al., 
2011a). Non-selective macroautophagy starts from the generation of the double layer 
isolation membrane, which expands to sequester cytosolic contents and encloses to form 
autophagosome that eventually fuses with lysosome (Eskelinen, 2005; Xie and Klionsky, 
2007). Selective autophagy specifically targets certain organelles or pathogens for 
autophagosome-dependent transport and lysosome-dependent degradation (Narendra et 
al., 2008; Thurston et al., 2009). 
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Macroautophagy is the most widely studied and best characterized process 
compared to other autophagy processes. My thesis work has mainly focused on 
macroautophagy, although the cellular machinery of my study would also be important 
for selective autophagy, since macroautophagy and selective autophagy share many 
proteins in common during the processes (Kim et al., 2008; Komatsu et al., 2007; Zheng 
et al., 2009b). The process of macroautophagy can be divided into five subsequent steps 
(Mizushima, 2009): (1) formation of isolation membrane (the membrane structure 
initially generated upon autophagy induction (2) expansion of the membrane structures in 
size; (3) maturation of the membrane vesicle to form the circular double membrane 
structure called autophagosome; (4) membrane fusion of autophagosome with the 
lysosome; (5) degradation of the autopahgosomal contents in the lysosome (Figure 2).  
Below is a brief discussion about each of those steps. 
 (1) Formation of the isolation membrane: The autophagy process is initiated with 
the formation of a membrane compartment termed phagophore or isolation membrane 
(Militello and Colombo, 2011; Mizushima et al., 2001). The membrane structure has 
been proposed to originate from multiple sources such as the ER (Hayashi-Nishino et al., 
2009; Yla-Anttila et al., 2009), mitochondria (Hailey et al., 2010), Golgi (Geng et al., 
2010; Nair et al., 2011), trans-golgi network (TGN) (Young et al., 2006) and plasma 
membrane (Moreau et al., 2011; Ravikumar et al., 2010). The ER has been considered as 
the major source of the membrane. In a proposed model, an “Ω”-shaped membrane 
structure or “omegasome” is formed on the surface of the ER (Axe et al., 2008; Hayashi-
Nishino et al., 2009).  Omegasome was proposed to function as a platform for the 
formation of the isolation membrane (Hayashi-Nishino et al., 2009; Mari et al., 2011; 
Yoshimori and Noda, 2008). The molecular mechanisms underlying the formation of the 
isolation membrane remain poorly understood.  Recent genetic and biochemical studies 
have shown that Atg1/ULK1 protein kinase is important for the formation of the isolation 
membrane (Chan et al., 2007; Ganley et al., 2009; Hosokawa et al., 2009a; Itakura and 
Mizushima, 2010; Kuroyanagi et al., 1998; Yan et al., 1998; Young et al., 2006).   
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The formation of the isolation membrane also requires Beclin 1 and its associated 
proteins. Beclin 1, the mammalian orthologue of yeast Atg6, interacts with hVps34 
(human vacuolar protein sorting 34 homologue), a lipid kinase that is also called PI3KC3 
(class III phosphatidylinositol-3-kinase) (Funderburk et al., 2010; Itakura et al., 2008; 
Liang et al., 2008; Matsunaga et al., 2009).  Beclin 1 stimulates the lipid kinase activity 
of hVps34 to recruit additional Atg proteins (Wirawan et al., 2012).  Beclin 1 and hVps34 
interact with Atg14L, a key molecule involved in the formation of the isolation 
membrane (Itakura et al., 2008; Matsunaga et al., 2010; Matsunaga et al., 2009),  The 
hVps34 protein complex containing Atg14L catalyzes the phosphorylation of 
phosphatidylinositol (PI) to produce phosphatidylinositol-3-phosphate (PI3P).  PI3P 
recruits proteins containing the Fab1p/YOTB/Vac1p/EEA1 (FYVE) motif, such as 
double FYVE-containing protein 1 (DFCP1), WD-repeat domain phosphoinositide-
interacting protein-1 (WIPI-1) and WIPI-2 (Polson et al., 2010). DFCP1, which is 
distributed diffusely throughout the ER or the Golgi, is re-distributed onto omegasome in 
response to starvation (Itakura and Mizushima, 2010; Matsunaga et al., 2010; Polson et 
al., 2010). WIPIs also translocate to the site of isolation membrane formation upon 
autophagy induction (Itakura and Mizushima, 2010; Polson et al., 2010). The recruitment 
of DFCP and WIPIs is crucial for the formation of the isolation membrane (Matsunaga et 
al., 2010; Polson et al., 2010).  The formation of isolation membrane also depends on an 
ER membrane protein called vacuole membrane protein 1 (VMP1) (Ropolo et al., 2007).  
Through acquisition of extra lipids, the isolation membrane further expands and engulfs a 
portion of cytoplasmic material targeted for destruction to form the nascent double-
membrane autophagosome (Itakura and Mizushima, 2010).  
  (2) Elongation of double membrane structure. The elongation step of the 
isolation membrane requires two ubiquitin-like conjugation systems. The first is the 
Atg12–Atg5 conjugation, which is produced by Atg7 (E1-like) and Atg10 (E2-like) 
enzymes. Atg12 is conjugated to Atg5 and these two proteins form a 
protein complex with Atg16L (Fujita et al., 2008).  The Atg16L-Atg12-Atg5 complex is 
localized to the isolation membrane and plays an essential role for the membrane 
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expansion (Xie and Klionsky, 2007). This membrane expansion process requires fusion 
of membrane that depends on the soluble N-ethylmaleimide-sensitive factor attachment 
protein receptors (SNARE) proteins such as  vesicle-associated membrane protein 7 
(VAMP7) and its partners (Moreau et al., 2011).  The second conjugation system 
involves the phosphatidylethanolamine (PE)-conjugated Atg8 proteins (Xie and 
Klionsky, 2007). In mammalian cells, several homologues of Atg8 have been identified.  
They are microtubule-associated protein 1 light chain 3A and B (LC3A and LC3B), 
Golgi-associated ATPase enhancer of 16 kDa (GATE16), gamma-aminobutyric acid 
receptor-associated protein (GABARAP), and GABARAP-like protein (GABARAPL or 
Atg8L). The PE-conjugation of Atgt8 homologues is mediated by Atg7 and Atg3 (E2-
like) enzymes (Nakatogawa et al., 2009; Weidberg et al., 2010).  Atg3 and Atg12 recruit 
LC3 close to PE in the membrane. The Atg16L-Atg12-Atg5 complex provides the 
scaffold for LC3 to transfer LC3 from Atg3 to PE, and the lipidation of LC3 propels 
membrane elongation (Fujita et al., 2008). 
Another key molecule involved in the membrane elongation process is Atg9, a 
multi-spanning transmembrane protein.  Atg9 resides in a juxta-nuclear region that 
contains the TGN and peripheral late endosomes and it plays an important role in 
sequestrating membrane for autophagosom (Saitoh et al., 2009; Young et al., 2006). 
(Young et al., 2006). Atg9 was found to undergo trafficking between the TGN, Rab9- and 
Rab7-positive endosomes and the LC3-positive autophagosome precursor membranes in 
response to starvation. This process is important for the formation and elongation of the 
isolation membrane (Webber and Tooze, 2010).  It has been shown that the trafficking of 
Atg9 requires the activity of ULK1 and appears to depend on hVps34 (Young et al., 
2006).   
(3) Maturation of the double membrane structure: The inner and outer bilayer 
membranes eventually fuse to have one inside the other as two distinct and enclosed 
membranes, and this marks the maturation of the double-membrane vesicle called 
autophagosome. After closure of autophagosome, it undergoes maturation process by 
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fusion events with early and late endosomal vesicles prior to fusion with the lysosomes 
(Chua et al., 2011; Liang et al., 2008; Peplowska et al., 2008).  hVps34 is involved not 
only in the early step of the isolation membrane formation but also in the step of 
autopahgosome maturation. hVps34 interacts with UVRAG (UV radiation resistance 
associated gene) and the complex regulates the autophagosome maturation through 
recruitment and activation of Rab7 GTPase via its direct interaction with C-VPS/HOPS 
complex (class C vacuolar protein sorting/homotypic vacuole fusion protein sorting) 
(Liang et al., 2008; Peplowska et al., 2008; Sun et al., 2010). The PI3KC3-UVRAG-
HOPS complex also interacts with Rubicon (RUN domain and cysteine-rich domain 
containing Beclin-1-interacting protein) via UVRAG (Matsunaga et al., 2009; Zhong et 
al., 2009). Rubicon is an inhibitor of UVRAG thus negatively acting in the 
autophagosome maturation process (Matsunaga et al., 2009; Sun et al., 2010; Zhong et 
al., 2009).  Moreover, the hVps34 complex interacts with AMBRA 1 (activating 
molecule in Beclin 1-regulated autophagy-1) (Fimia et al., 2007) and Rab5 (Ravikumar et 
al., 2008). The maturation of the autophagosome is also regulated by other factors such as 
the ATPase suppressor of K(+) transport growth defect-1 (SKD1) and the cytoskeleton 
(Kang et al., 2011).  
(4) Fusion of autophagosome with the lysosome: Autophagosomes fuse with 
lysosomes (or vacuoles in yeast) to form autolysosomes, in which the cytoplasmic cargo 
is degraded by lysosomal hydrolases. Two SNARE proteins, Vti1b and VAMP8, mediate 
the fusion of autophagosomes with lysosomes (Furuta et al., 2010; Nair et al., 2011). 
Vti1b is derived from autophagic compartments, whereas VAMP8 originates from 
lysosomes. Knockdown of those SNAREs inhibited the fusion of autophagosomes with 
lysosomes, thereby disturbing autophagosomal fusion with lysosomes (Furuta et al., 2010; 
Nair et al., 2011). Tectonin domain-containing protein (Tecpr1) was also shown to 
promote autophagosome-lysosome fusion (Chen et al., 2012). Tecpr1 was originally 
found to be necessary for selective autophagic targeting of bacteria pathogens (Ogawa et 
al., 2011), and it interacts with Atg5 and WIPI-2 (Behrends et al., 2010). Later, it was 
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discovered that Tecpr1 localizes to autolysosome membrane and recruits Atg5. The 
binding of Tecpr1 to the Atg12-Atg5 conjugate prohibits Atg16L from binding, and 
further recruits PI3P. The connection of Tecpr1 with Atg12-Atg5 and PI3P promotes the 
specific fusion between autophagosomes and lysosomes (Chen et al., 2012). 
(5) Degradation of delivered content. The organelles and macromolecules 
delivered by autophagosome are degraded in the lysosome. The lysosome contains 
hydrolyzing enzymes that break down proteins, lipids and carbohydrates. The resulting 
degradation products are then released back to the cytoplasm through the activity of 
membrane permeases and are recycled as cellular building blocks (Eskelinen, 2005). The 
degradation of autolysosomal products is also necessary for the attenuation of autophagy 
and the reformation of functional lysosomes (Yu et al., 2010).  Many human diseases, 
such as Hurler syndrome, Gaucher disease, Tay-Sachs disease, Sanfilippo syndrome and 
Hunter syndrome, are associated with defects in lysosomal digestive functions (reviewed 
in (Winchester et al., 2000)). 
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Figure 2. Illustration of the major stages in autophagy. The autophagy process can be 
divided into several stages.  (1) Formation of the isolation membrane. The ULK1 
complex and Beclin 1-associated class III phosphatidylinositol-3-kinase (PI3KC3) 
complex regulate the formation of the isolation membrane. PI3KC3 catalyzes the 
conversion of phosphatidylinositol (PI) to phosphatidylinositol-3-phosphate (PI3P), 
which is recognized by double FYVE-containing protein 1 (DFCP1) and WD-repeat 
domain phosphoinositide-interacting protein (WIPI). The recruitment of DFCP and WIPI 
is crucial for the formation of the isolation membrane. (2) Elongation of the isolation 
membrane. Two ubiquitin-like conjugation systems are required in this process. The first 
is the Atg12–Atg5 conjugation, and these two proteins form a complex with Atg16L. The 
second conjugation system involves the phosphatidylethanolamine (PE) conjugation of 
Atg8 proteins.  There is another multi-spanning transmembrane protein Atg9, involved in 
the double membrane elongation. Atg9 undergoes trafficking between the TGN, Rab9-
and Rab7-positive endosomes and the LC3-positive autophagosome precursor 
membranes in response to starvation to provide membrane source for autophagy.(3) 
Maturation of double membrane structure. The inner and outer bilayer membranes 
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eventually fuse to have one inside the other as two distinct and enclosed membranes, and 
this marks the maturation of the double-membrane vesicle called autophagosome. 
PI3KC3 is involved in the step of autopahgosome maturation. (4) Fusion of 
autophagosome with the lysosome: Autophagosomes fuse with lysosomes to form 
autolysosomes, in which the cytoplasmic cargos are degraded by lysosomal hydrolases. 
(5) Degradation of delivered content. The organelles and macromolecules delivered by 
autophagosome are degraded in the lysosome.  
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II. Broad roles of autophagy in physiology and diseases 
Eukaryotic cells utilize autophagy to maintain the balance between the synthesis 
and degradation of macromolecules and organelles in response to nutrient deprivation, 
the availability of growth factors, and stress. Autophagy may contribute to cell survival 
under starvation by re-distributing nutrients for the most essential processes for cellular 
functions.  As a key cellular process in response to environmental changes, autophagy is 
implicated in a number of physiological and pathological processes.  In addition to its 
fundamental role in starvation adaption, autophagy is also important for embryo 
development, tissue differentiation, protection against neurodegeneration, pathogen 
processing, and cancer (Levine et al.; Mizushima, 2009; Rubinsztein, 2006). The 
following sections summarize the main functions of autophagy involved in physiology 
and human diseases. 
 
a. Roles in physiology, development and differentiation 
Energy metabolism 
In a study using the mouse model, autophagy was up-regulated in the liver, 
pancreas, kidney, skeletal muscle, and heart within 24 hours of starvation (Mizushima et 
al., 2004). The cellular contents digested by the autophagy process can be used for 
cellular energy, and the liver can convert nucleotides, amino acids, and lipids into glucose 
and ketone bodies that are distributed to other parts of the body (Rabinowitz and White, 
2010).  Mammalian cells in the body usually live in a relatively constant nutrient 
environment.  Nevertheless, autophagy is activated in the liver between meals to maintain 
its metabolic function (Mizushima and Klionsky, 2007).  Even when the nutrient intake is 
sufficient, a basal level of autophagy operates for housekeeping and homeostasis 
(Mizushima and Klionsky, 2007).  Autophagy has also been shown to regulate the 
breakdown of lipid droplets in the liver (Dong and Czaja, 2011; Singh et al., 2009a).  
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This alternative mechanism for lipid hydrolysis further highlights the significant function 
of autophagy in energy metabolism.  Lymphocytes rely on growth factor stimulation to 
consume extracellular nutrients, so the energy metabolism in lymphocytes is sensitive to 
not only nutrient supply but also to fluctuation in growth factor levels (Hubbard et al., 
2010; Mathew et al., 2007).  Autophagy is activated in lymphocytes when growth factors 
are deprived, and this appears to function to accommodate the bioenergetic need of 
lymphocytes.  
Development 
Autophagy is observed as an early event in fertilized oocytes and is essential 
during the pre-implantation phase (Tsukamoto et al., 2008). Autophagy is massively 
induced in undifferentiated oocytes within 4 hours of fertilization (Tsukamoto et al., 
2008). The mouse embryo cannot survive through the 4-cell to 8-cell stage if both the 
inherited maternal Atg5 and the oocyte specific Atg5 are eliminated.  Atg5 knockout in 
mice does not result in early embryonic lethality but these Atg5-/- mice exhibit 
abnormality in embryonic neuron ubiquitin inclusion body and reduction in neonate 
adipose tissue mass (Tsukamoto et al., 2008).  In late embryogenesis, a high level of 
autophagy is found only in limited tissues like the developing thymus (Mizushima et al., 
2004), suggesting a tissue-specific role of autophagy in the development. For fetus of 
vertebrates, the sufficient nutrient supply during embryo development is suddenly 
terminated at birth. Autophagy is broadly activated in tissues except in the brain within 
24 to 48 hours after birth to enable the neonates to survive the severe starved condition 
(Kuma et al., 2004).  Mice with knockout of Atg3 (Sou et al., 2008), Atg5 (Kuma et al., 
2004), Atg7 (Komatsu et al., 2005), Atg9 (Saitoh et al., 2009) or Atg16L (Saitoh et al., 
2008) appear normal at birth but die within 1 day, supporting the indispensable role of 
autophagy at this stage. 
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Differentiation 
During erythroid differentiation, erythroblasts release nuclei and degrade 
organelles before they are transformed into mature erythrocytes (Geminard et al., 2002). 
Mitochondrial clearance occurs during this process and it depends on autophagy.  ULK1 
knockout mice showed impaired clearance of mitochondria in reticulocytes (Kundu et al., 
2008).  Mice with haematopoietic cell-specific knockout of Atg7 accumulated damaged 
mitochondria in reticulocytes (Zhang et al., 2009a).  These reticulocytes undergo 
apoptosis and the mouse usually die at 8-14 weeks due to severe anemia (Zhang et al., 
2009a). 
The haematopoietic cell-specific Atg7 knockout mice mentioned above also have 
significant reduction in the numbers of T and B lymphocytes (Mortensen et al., 2010), 
possibly due to the increased cell apoptosis as a result of defective mitohagy. During the 
differentiation of T and B cells, mitochondrial content also goes through autophagic 
degradation (Pua et al., 2009). Lymphocyte-specific knockout of Atg5 or Atg7 in mice 
resulted in accumulation of mitochondria and subsequent increase in superoxide, making 
the cell more prone to apoptosis (Pua et al., 2009; Stephenson et al., 2009). This result 
suggests that autophagy is in charge of the clearance of mitochondria during the 
differentiation of T and B cells (Pua et al., 2009). 
Pre-adipocytes differentiate into adipocytes with a large accumulation of lipid 
droplets.  Knockdown of Atg7 or knockout of Atg5 in 3T3-L1 pre-adipocytes or in mouse 
embryonic fibrablasts (MEFs) decreased the accumulation of triglycerides and 
suppressed adipocyte differentiation (Baerga et al., 2009; Singh et al., 2009b).  
Adipocyte-specific knockout of Atg7 in mice has resulted in reduction of the white 
adipose tissue mass.  The reduction was accompanied with smaller sizes of adipocytes, 
increased mitochondrial content and lipid droplets, which are representative 
characteristics of brown adipocytes (Singh et al., 2009b; Zhang et al., 2009b).  Consistent 
with these cellular phenotypic changes, the adipocytes in the mutant mice expressed 
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UCP-1 and PGC-1α that are highly expressed in brown adipose tissue  (Singh et al., 
2009b).  The mice exhibited an improvement of insulin sensitivity in peripheral tissues. 
The beneficial outcome of insulin sensitivity with adipose Atg7 knockout in mice might 
be due to the higher content of brown adipocytes in adipose tissue.   
Host defense and immunity 
The autophagy pathway degrades not only endogenous components in the cell but 
also exogeneous pathogens, such as viruses, parasites and bacteria. The autophagy 
network is implicated in several pathways targeting the pathogens to the lysosome 
(Levine et al., 2011).  Pathogens that enter host cells by phagocytosis are surrounded by a 
vesicular structure called phagosome. The fusion of phagosomes with lysosomes or 
autophagosomes is dependent on autophagy proteins such as Atg5 and Atg7, and the 
envelopment of phagosomes involves autophagosomal membranes (Lee et al., 2010a; 
Sanjuan et al., 2007). These processes contribute to the presentation of major 
histocompatibility complex class II (MHC-II) antigen.  In dendritic cells, autophagy is 
required for the transport of viral nucleic acids to toll-like receptor-7 (TLR7) in 
endosomes and for the production of interferon-α (Lee et al., 2007).  The mechanism by 
which autophagy regulates cytokine secretion is not clear.  Mutations in Atg16L1 and 
Atg5 have been found to disrupt granule exocytosis in intestinal epithelial cells (Cadwell 
et al., 2008), and this might explain at least in part the role of autophagy in cytokine 
secretion. 
Aging and longevity 
Autophagy interacts with several longevity pathways in Caenorhabditis elegans, 
including insulin-like growth factor signaling, TOR signaling, and calorie restriction. 
These pathways require the activity of autophagy in their effect of lifespan extending 
(reviewed in (Jia and Levine, 2010)). Mouse models with impaired autophagy have 
shown accelerated aging (Komatsu et al., 2005), suggesting that a reduced level of 
autophagy might facilitate aging.  This role of autophagy might explain why caloric 
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restriction, which improves autophagy, slows down the aging process (Bergamini, 2005). 
One of the major contributions of autophagy might be the protection of DNA damages 
resulting from cellular stress. Autophagy-defective cells accumulate damaged checkpoint 
proteins or repair proteins without efficient turnover.  Due to suppressed autophagic 
recycling of cellular contents, these cells may lack sufficient energy for proper DNA 
replication and repair (Jin and White, 2007; Mathew et al., 2007).  Although autophagy 
promotes cell survival by dealing with stress, an excess level of autophagy could result in 
cell death (Maiuri et al., 2007).  Drosophila fat body that over-expresses Atg1 showed 
reduction in cell size and ultimately resulted in cell loss (Martin and Baehrecke, 2004). 
Catalase is the major enzymatic scavenger for reactive oxygen species (ROS) that can 
cause cellular oxidative stress and facilitate aging process. Caspase inhibition induces the 
selective autophagic degradation of catalases, and causes abnormal ROS accumulation 
that leads to necrotic cell death. (Yu et al., 2006).  Thus, over-activated autophagy could 
cause a harmful effect and facilitate aging process. 
b.         Roles of autophagy in human diseases 
Although autophagy may be dispensable in rapidly proliferating cells, its 
housekeeping and renewing function must be important for non-dividing differentiated or 
senescent cells, such as cardiac- and skeletal-muscle cells, hepatocytes, and neurons. 
Given the diverse involvement of autophagy in physiological processes, it is not 
surprising to see that too much or too little of autophagy level could lead to many 
diseases, which include cardiac- and skeletal-muscle diseases, liver diseases, infectious 
diseases, neurodegeneration and cancer. 
Neurodegeneration 
Autophagosomes accumulate in the neurons of patients with neurodegenerative 
diseases, such as Alzeheimer’s disease, Parkinson’s disease, and Hungtington’s disease, 
indicating the abnormal level of autophagy in these neurons (Hara et al., 2006; Komatsu 
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et al., 2006).  Autophagy participates in the clearance of aggregate-prone mutant proteins, 
such as polyglutamine tract-containing proteins in Hungtington’s disease, mutant alpha-
synucleins in familial Parkinson’s disease, and mutated tau proteins in frontotemporal 
dementia (Martinez-Vicente and Cuervo, 2007; Rubinsztein, 2006; Rubinsztein et al., 
2005).  Oligomeric and aggregated proteins tend to have a higher toxicity, and because 
they have difficulty in unfolding and passing through the narrow pore of proteasomal 
barrel, they are better substrates for autophagic degradation.  It needs to be clarified 
further whether an autophagy defect is a cause of the neurodegenerative diseases or the 
higher level of accumulated autophagosomes is simply a consequence of the increased 
protein aggregates.  The expression of Beclin 1 is reduced by 60 to 70 % in 
Alzheimer's disease (Jaeger and Wyss-Coray, 2010).  In Huntington’s disease, mutations 
in the dynein motor machinery that impair the autophagic clearance of aggregate-
prone proteins were identified (Ravikumar et al., 2005). Autophagy-stimulatory agents 
such as rapamycin analogs and lithium choloride have a high promise as 
chemotherapeutics to prevent neurodegeneration (Rubinsztein et al., 2007). 
Liver disease  
The participation of autophagy in the liver functions is manifested by both genetic 
disorders and genetic manipulation studies.  Alpha1-antitrypsin deficiency is a common 
genetic liver disease that occurs as a consequence of a point mutation in the alpha1-
antitrypsin Z (ATZ) gene (Stoller and Aboussouan, 2005).  The ATZ protein is usually 
secreted into the blood and body fluids and functions as an inhibitor of neutrophil 
proteases, while the mutation leads to retaining of the protein in the ER of hepatocytes. 
Autophagy is activated by ER accumulation of ATZ and the disposal of the mutant ATZ 
protein is largely dependent on autophagy (Perlmutter, 2006). Atg5-deficient cells 
showed a reduction in the degradation of the mutant ATZ protein (Kamimoto et al., 2006), 
indicating the important role of autophagy in the clearance of this protein.  Autophagy is 
also important in the development of alcoholic liver disease (ALD). Sustained over-
consumption of alcohol results in accumulation of oxidative stress, lipid droplets and 
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damaged mitochondria in hepatocytes, which is the base of  ALD (O'Shea et al., 2010). 
Autophagy has a protective effect against the impairment of alcohol in the liver. Ethanol-
induced ROS production activates autophagy, which selectively removes damaged 
mitochondria and lipid droplets in hepatocytes (Ding et al., 2011). Mice treated with 
rapamycin to increase autopahgy showed  reduced hepatotoxicity after  acute ethanol 
exposure, and this potential protective role of autophagy against alcoholic liver injury has 
led to attempts of therapeutic approaches to treat ALD by autophagy modulation (Ding et 
al., 2010).  
Skeletal- and cardiac-muscle disease 
Defective autophagy contributes to inherited skeletal- and cardiac-muscle diseases.  
Danon disease, characterized by cardiomyopathy, myopathy, and mental retardation, is 
caused by a mutation in the lysosomal-associated membrane protein-2, which is 
associated with excessive autophagosomal accumulation (Tanaka et al., 2000). Pompe 
disease, another skeletal- and cardiac-muscle disorder, results from deficiency of acid 
alpha-glucosidase, a glycogen-degrading lysosomal enzyme (Fukuda et al., 2006). The 
defective lysosomal function provokes abnormal protein trafficking and accumulation of 
autophagosomes. 
Autophagy also represents an important response to cardiac stresses, such as 
ischemia or pressure overload. Patients with coronary artery disease, hypertension, aortic 
valve disease, and congestive heart failure were found to have an accumulation of 
autophagosomes in their cardiac biopsy tissues (Terman and Brunk, 2005). Therefore, 
autophagy may play a dual role in cardio-protection.  Excessive autophagy causes 
damage in  myocytes, while in sudden cardiac event autophagy is necessary.  The current 
consensus is that the cytoprotective effects of autophagy outweigh its adverse effect in 
myocyte degeneration, so promotion of autophagy is being considered as a potential 
therapeutic strategy in acute cardiac stress conditions (Przyklenk et al., 2012).  
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Cancer 
The Beclin 1 gene was identified as a haploid insufficient tumor suppressor gene 
(Liang et al., 1999).  The gene was mapped to a tumor susceptibility locus about 150 kb 
centromeric to the breast cancer BRCA1on human chromosome 17q21. Monoallelic loss 
of chromosome 17q21 is prevalent in human prostate, breast and ovarian cancer (Li et al., 
2010).  The Beclin 1+/− mice showed increased incidence of spontaneous tumors in 
addition to reduced autophagy activity (Qu et al., 2003).  Bcl-2 interacts with Beclin 1 
and it functions as an oncogene by blocking apoptotic cell death.  Bcl-2 also negatively 
regulates Beclin 1-dependent autophagy and autophagic cell death (Pattingre and Levine, 
2006). Other autophagy proteins that function as tumor suppressors include Bif-1, death-
associated protein kinase 1 (DAPK1), liver kinase B1 (LKB1), phosphatase and tensin 
homolog (PTEN), and UVRAG. Activation of the class I PI3K-Akt-mammalian target of 
rapamycin (mTOR) signaling pathway suppresses autophagy (Wu et al., 2009), and 
mutations in PIK3CA and Akt and amplification/copy gain of PIK3CB and Akt are found 
in many cancers (Ogita and Lorusso, 2011; Xing, 2010). The tumor suppressor p53 also 
regulates autophagy but its effect could be positive or negative depending on its sub-
cellular localization (Morselli et al., 2009).  
The relation between autophagy and cancer is paradoxical. At the initiation stage 
of some cancer, autophagy has a negative effect for tumor growth (Degenhardt et al., 
2006). The damaged cellular content in tumor-prone cells can be removed by autophagy, 
which may alleviate the cellular potential to develop as tumor. Autophagy exerts anti-
tumor effects in such circumstances. On the other hand, the external environment for 
tumor cells is often short of nutrients, growth factors, and oxygen due to restricted blood 
supply.  Autophagy can promote tumor cell survival in such an environment that is 
remote from blood and nutrient supply  (Morselli et al., 2009). In developed tumor cells, 
the regeneration of amino acids through autophagy may provide metabolic substrates and 
energy for prolonged proliferation (Degenhardt, Mathew et al. 2006). Autophagy is often 
induced in cancer cells under chemo- or radio-therapy, contributing to the resistance of 
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cells to the anti-tumor therapies (Morselli et al., 2009).  Inhibition of autophagy is 
therefore considered as a potential useful strategy in combination with the cancer 
therapies (White and DiPaola, 2009). Most of these trials combine cytotoxic 
chemotherapy with hydroxychloroquine, which inhibits the terminal lysosome 
degradation step to block autophagy flux (Chen and Karantza, 2011).   
Other diseases 
In Paneth cells of the intesine, autophagy plays a protective role against the 
damage from inflammation thereby suppressing the development of Crohn’s disease 
(Cadwell et al., 2008). Autophagy is also found to act against the deleterious 
consequences of obesity (Yang et al., 2010). Although the mechanism for this protection 
is not clear, a clinical application of autophagy stimulation is under consideration for 
obesity-related disease prevention (Tanaka et al., 2012). Autophagy was reported to 
facilitate the progression of acquired immune deficiency syndrome (AIDS) (Espert et al., 
2007). Human immunodeficiency virus-infected T cells expressing 
envelope glycoproteins (Env) induce a higher activity of autophagy in uninfected 
CD4+ T cells that is triggered by the contact of Env with chemokine receptor type 4 
(Espert et al., 2007). The Env-mediated autophagy leads to T cell apoptosis, which is 
commonly found in patient with AIDS (Espert and Biard-Piechaczyk, 2009).  
In summary, autophagy is required in major physiological processes and is 
implicated a number of prevalent diseases, implying that the regulation of autophagy is 
essential for the health of human body. 
 
III. The ULK1 complex, the key element for autophagy initiation 
 Despite the well-appreciated functions of autophagy in physiology and diseases, 
the mechanism of autophagy induction remains elusive.  My thesis work has intended to 
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better understand the molecular mechanisms of the early steps of autophagy induction 
with a particular focus on the ULK1 protein complex. This section will introduce the 
ULK1 complex in more detail, and discuss the functions and the regulatory mechanisms 
of the ULK1 complex. 
 
a.        The Atg1/ULK1 protein kinase 
A cornerstone for our understanding of autophagy is a genetic screen in 
Saccharomyces Cerevisiae that discovered a set of autophagy-related genes including 
Atg1, an evolutionarily conserved Ser/Thr kinase that functions at the most upstream step 
of autophagy induction (Matsuura et al., 1997).  In C. elegans, the Atg1 homologue is 
uncoordinated-51 (Unc-51), which was shown to affect starvation-dependent formation 
of dauer (the stage that the larva goes into stasis and survives harsh conditions) 
(Melendez et al., 2003). Interestingly, Unc-51 was originally discovered in a screen for 
uncoordinated movement in C. elegans (Kuroyanagi et al., 1998; Yan et al., 1998), and 
that is where the name comes from.  It was found later that the unc-51 protein participates 
in axon guidance (Lai and Garriga, 2004) and neuronal vesicular movement (Sakamoto et 
al., 2005), which explains its role in movement coordination. Drosophila Melanogaster 
has one Atg1 homolog identified so far, and deletion of the Drosophila Atg1 gene results 
in a defective autophagy phenotype (Scott et al., 2004).  Similar to Unc-51 in C. elegans, 
the Drosophila Atg1 is also crucial in neuronal development (Toda et al., 2008), possibly 
through interacting with cytoskeleton motor proteins to direct synaptic vesicle transport 
(Chen et al., 2008; Toda et al., 2008). The shared funcrion of Atg1 and Unc-51 in 
neuronal vesicular trafficking and autophagy implies an important role of cytoskeleton in 
both processes. 
While yeast, C. elegans and Drosophila have only one homolog for Atg1 
(Kamada et al., 2000; Matsuura et al., 1997), mammals have five members of Atg1 
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homologues that are named ULK1, ULK2, ULK3, ULK4, and serine/threonine kinase-36 
(STK36) (Figure 3). Among them, STK36 is remotely related to the Drosophila Fused 
protein.  All the five ULK family kinases have a highly conserved N-terminal kinase 
domain (Chan et al., 2007; Hara et al., 2008; Jung et al., 2009; Kundu et al., 2008; Yan et 
al., 1998; Yan et al., 1999; Young et al., 2009).  ULK1 and ULK2, which were shown to 
regulate autophagy (Chan et al., 2007; Chan et al., 2009; Jung et al., 2009), contain a 
proline/serine-rich region in the middle.  The two kinases also contain a C-terminal 
region involved in interaction with other autophagy proteins such as Atg13 (Yan et al., 
1999). In contrast to the neonatal lethality when other major autophagy genes (Atg3, 
Atg5, Atg7, Atg9) are knocked out in mice (Komatsu et al., 2005; Kuma et al., 2004; 
Saitoh et al., 2009; Sou et al., 2008), ULK1 knock-out mice are viable (Kundu et al., 
2008). This appears to be due to the complementation by ULK2.  A recent study has 
shown that overexpression of ULK3 activated autophagy in IMR-90 cell lines (Young et 
al., 2009).  Moreover, upon autophagy induction by amino acid or serum depletion, 
ULK3 co-localized with the Atg12-Atg5 conjugate in a punctuate pattern (Young et al., 
2009). Thus, ULK3 appears to be involved in a specific step of autophagy and its 
function is different from that of ULK1 and ULK2.  It remains unknown whether ULK4 
and STK36 regulate autophagy.   
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Figure 3. Sequence comparison of Atg1 homologues in different species. 
Domain structures of Caenorhabditis elegans Unc51, Saccharomyces cerevisiae 
Atg1,  Drosophila Atg1, homo sapiens ULK1,  ULK2, ULK3 , ULK4, and STK36  
amino acid sequences (Jung et al., 2010). Sequence of amino acid encoding the starting 
and ending  residues for each domain is indicated. 
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b.        The Atg1/ULK complexes 
In yeast, Atg1 interacts with Atg13, Atg17, Atg29 and Atg31 (Funakoshi et al., 
1997; Kabeya et al., 2009). The interaction of Atg1 with Atg13 and Atg17 is regulated in 
a manner dependent upon the kinase activity of Atg1 and TOR (target of rapamycin), 
whereas the interaction of Atg17 with Atg29 and Atg31 appear to be consistent (Cheong 
et al., 2005; Kabeya et al., 2009).  In Drosophila, Atg1 binds to Atg13 but it has not been 
determined whether Atg1 has other binding partners (Chang and Neufeld, 2009).  In 
contrast to the interaction between yeast Atg1 and Atg13, the interaction between 
Drosophila Atg1 and Atg13 is not regulated by TOR activity (Chang and Neufeld, 2009).  
Drosophila Atg13 appears to function positively and negatively on Atg1 and autophagy 
(Chang and Neufeld, 2009).  In C. elegans, Unc-51 directly interacts with epg-1 that is a 
homolog of Atg13 (Tian et al., 2009). Knockout of epg-1 inhibited autophagy, suggesting 
that the Unc51-epg1 complex might have the conserved function in autophagy (Tian et 
al., 2009). 
In mammalian cells, ULK1 and ULK2 interact with multiple proteins including 
mammalian Atg13.  The mammalian Atg13 constitutively interacts with both ULK1 or 
ULK2 and plays crucial roles in autophagy induction (Ganley et al., 2009; Hosokawa et 
al., 2009a; Jung et al., 2009).  ULK1 and ULK2 also interact with FIP200 (Focal 
adhesion kinase family interacting protein of 200 kDa) (Hara et al., 2008)(Ganley, Lam 
du et al., 2009; Hosokawa, Hara et al., 2009; Jung, Jun et al., 2009.  FIP200 has been 
postulated to be a functional homologue of yeast Atg17 in mammalian cells (Hara et al., 
2008), although their sequence similarity is low.  FIP200 is important for the localization 
of ULK1 to the isolation membranes (Hara et al., 2008).  Atg13 and FIP200 do not 
contain any enzymatic domains and likely function as scaffolding proteins in recruiting 
substrates of ULK (Chan et al., 2009; Ganley et al., 2009; Hosokawa et al., 2009a; Jung 
et al., 2009).  Atg101, which does not show any homology with known autophagy 
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proteins, interacts with ULK1 and Atg13 and regulates autophagy induction (Mercer et 
al., 2009). These ULK binding proteins are potential substrates of ULK1 (Jung et al., 
2009), while their functions remain largely unknown. 
Recent studies have shown that ULK1 can interact with the Hsp90-Cdc37 
chaperone complex  (Behrends et al., 2010; Joo et al., 2011).  ULK1 was also found to 
interact with ubiquitin-specific protease 10 (Sowa et al., 2009), implying a potential link 
between the lysosome-dependent autophagic degradation pathway and the proteasome-
dependent degradation pathway.  ULK1 also interacts with mammalian target of 
rapamycin complex 1 (mTORC1) (Chan et al., 2009; Hosokawa et al., 2009a; Jung et al., 
2009) and 5’ AMP-activated protein kinase (AMPK) (Egan et al., 2011; Kim et al., 2011; 
Shang et al., 2011). mTOR and AMPK are key nutrient- and energy-sensing kinases 
(Hardie et al., 2012; Laplante and Sabatini, 2012).  These two kinases phosphorylate and 
regulate ULK1 (Egan et al., 2011; Kim et al., 2011; Shang et al., 2011). The regulation of 
ULK1 by mTORC1 and AMPK will be discussed in the following section in detail. 
 
c.        Regulation of the Atg1 complex in lower eukaryotes 
TOR is a key negative regulator of autophagy induction (Kamada et al., 2004). As 
an evolutionarily conserved serine/threonine protein kinase that belongs to the 
phosphatidylinositol kinase-related kinase family, TOR is the major nutrient-sensing 
protein kinase in eukaryotes and its activity is enhanced by high nutritional and energy 
status (Sengupta et al., 2010).  Through sensing the cellular nutritional status, TOR 
regulates cellular growth and autophagy. Nutrient starvation or specific TOR inhibitors 
like rapamycin can induce autophagy, and the induction was found to depend on the 
active state of Atg1 (Kamada et al., 2000; Matsuura et al., 1997).  These studies have 
suggested that Atg1 mediates the TOR inhibitory signaling to the autophagy induction 
machinery. The relation between TOR and Atg1 has been verified in several lower 
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eukaryotes such as S. cerevisiae, Dictyostelium discoideum, C. elegans and Drosophila 
(Melendez et al., 2003; Otto et al., 2004; Scott et al., 2007). 
In yeast, TOR inhibits autophagy by destabilizing the association between Atg1 
and its binding partners (Funakoshi et al., 1997; Kabeya et al., 2005; Kabeya et al., 2009; 
Kamada et al., 2000; Kawamata et al., 2008).  Under nutrient-enriched conditions, TOR 
phosphorylates Atg13 at multiple sites (Kamada et al., 2010).  As a consequence, the 
phosphorylation induces dissociation of Atg13 from Atg1, thus suppressing autophagy 
induction (Funakoshi et al., 1997; Kabeya et al., 2005; Kamada et al., 2000). When TOR 
is inhibited under starvation conditions, Atg13 is no longer phosphorylated by TOR.  
Atg1 is then able to interact with Atg13, and the kinase activiy of Atg1 is enhanced 
(Kamada et al., 2009) (Figure 4). 
The yeast protein kinase A (PKA) was found to negatively regulate autophagy  
because activation of  PKA activity inhibited autophagy and inactivation of the PKA 
pathway induced autophagy (Stephan et al., 2010). The regulation of PKA on autophagy 
was thought to be mediated through the Atg1 complex. PKA directly phosphorylates 
Atg1 (Budovskaya et al., 2005) and Atg13 (Stephan et al., 2010). The phosphorylation by 
PKA promotes Atg13 localization to the pre-autophagosome (PAS, the membrane 
origination of autophagosome in yeast), and the phosphorylation sites are distinct from 
the TOR phosphorylation sites, indicating PKA and TOR function independently to 
regulate autophagy through the Atg1/Atg13 complex. The yeast AMPK homolog sucrose 
non-fermenting 1 (Snf1) can positively regulate autophagy (Wang et al., 2001b), but the 
exact mechanism is not understood.  Snf1 is regulated by Elm1, Sak1, Tos3, and ROS 
(Hedbacker and Carlson, 2008) as well as by TORC1 (Orlova et al., 2006). 
In contrast to the TOR-dependent interaction between Atg1 and Atg13 in yeast, 
the Atg1-Atg13 interaction in Drosophila is independent of TOR (Chang and Neufeld, 
2010). (Figure 5). The nutritional status regulates the PI3K-Akt-TOR pathway and as a 
consequence, regulates autophagy induction. This regulation is in a manner dependent 
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upon Atg1 (Dutta and Baehrecke, 2008; Scott et al., 2007). Under nutrient-enriched 
conditions, the active Drosophila TOR hyperphosphorylates Atg1 and phosphorylates 
Atg13 to suppresses autophagy. Atg1 also phosphorylates itself. Under starvation 
conditions, the inactive TOR no longer phosphorylates Atg1 and Atg13. Atg1 still 
autophosphorylate and it phosphorylates Atg13 to induce autophagy (Chang and Neufeld, 
2010).   
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Figure 4. Regulation of the Atg1 complex in Saccharomyces cerevisiae. 
The yeast Atg1 complex consists of Atg1, Atg13, Atg17, Atg29 and Atg31 
(Funakoshi et al., 1997; Kabeya et al., 2009). Under nutrient rich conditions, TOR 
phosphorylates Atg13 and induces dissociation of Atg13 from Atg1 and its other binding 
partners (Atg17, Atg29 and Atg31) (Funakoshi et al., 1997; Kabeya et al., 2005; Kamada 
et al., 2000). When TOR is inhibited in starvation conditions, Atg13 is no longer 
phosphorylated by TORC1 and stably interacts with other proteins in the complex.  In 
this state, the kinase activiy of Atg1 is increased and autophagy is induced (Kamada et 
al., 2009). The yeast PKA negatively regulates autophagy (Stephan et al., 2010)  by 
phosphorylating Atg1  (Budovskaya et al., 2005) and Atg13  (Stephan et al., 2010). The 
"P" sign for phosphorylation is shown in the same color as the kinase responsible for the 
phosphorylation. 
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Figure 5. Regulation of the dAtg1 complex in Drosophila. 
The Drosophila Atg1 (dAtg1) interacts with Atg13 independently of TOR 
activity. Active TOR phosphorylates Atg13 and hyperphosphorylates dAtg1 to 
suppresses autophagy. dAtg1 autophorylates. When TOR is inactive, dAtg1 still 
phosphorylate itself and it also phosphorylates Atg13 to induce autophagy. The "P" sign 
for phosphorylation is shown in the same color as the kinase responsible for the 
phosphorylation. 
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 d.        Regulation of the ULK1 complex in mammalian cells 
The regulatory mechanism of Atg1 in lower eukaryotes is partially conserved in 
higher eukaryotes. mTOR, like yeast TOR, plays a key role in sensing nutritional and 
energy status of cells to regulate cell growth and autophagy. The function of mTOR is 
implicated in many pathological conditions such as cancer, aging, longevity, metabolic 
disorders, and neurodegenerative diseases (Cota, 2009; Garelick and Kennedy, 2010; 
Kapahi et al., 2010; Liu et al., 2009a; Sabatini, 2006). mTOR forms two distinct protein 
complexes. The complex containing raptor (regulatory-associated protein of mTOR) is 
called mTORC1 (mTOR complex 1), while the complex containing rictor (raptor-
independent companion of mTOR) is called mTORC2 (Guertin and Sabatini, 2007; 
Jacinto et al., 2006; Kim et al., 2002; Sarbassov et al., 2004).  mTORC1 is responsible for 
sensing cellular nutrient and energy status and for the regulation of cell growth and 
autophagy (Jung et al., 2010; Sabatini, 2006). 
mTOR responds not only to the cellular availability of specific nutrients and stress 
but also to circulating growth factors such as insulin which corresponds to the nutritional 
status of a multicellular organism.  Insulin or insulin-like growth factors activates the 
PI3K-Akt pathway. As a consequence, Akt phosphorylates TSC2 (tuberous sclerosis 
complex 2) and thereby inhibiting the GTPase activating function of TSC2 toward a 
small GTPase named Rheb (Inoki et al., 2003a; Inoki et al., 2002; Potter et al., 2002; 
Zhang et al., 2003). Rheb is an activator of mTORC1, thus the inhibition of TSC2 by Akt 
results in activation of mTORC1. Akt can also affect mTORC1 activity through 
phosphorylation of the proline-rich Akt substrate (PRAS40) (Sancak et al., 2007; Vander 
Haar et al., 2007), a component of mTORC1 (Kovacina et al., 2003). mTORC1 can also 
be activated by other growth factors such as epidermal growth factor (EGF) and platelet-
derived growth factor (PDGF)  via mitogen-activated protein kinase (MAPK) activation 
(Carriere et al., 2008). 
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In nutrient-enriched conditions, mTOR interacts with ULK1 and phosphorylates 
ULK1 at Ser758 (Ser757 in mouse ULK1) (Kim et al., 2011; Shang et al., 2011) and 
Ser658 (Shang et al., 2011) (Figure 6). These phosphorylations strengthen the interaction 
between mTOR and ULK1 and inhibit ULK1’s kinase activity (Chan et al., 2009; Ganley 
et al., 2009; Hosokawa et al., 2009a; Jung et al., 2009). Unlike the interaction between 
Atg1 and Atg13 in yeast, the interaction between ULK1 and Atg13 in mammalian cells is 
not regulated by mTORC1 (Chan et al., 2009; Ganley et al., 2009; Hosokawa et al., 
2009a; Jung et al., 2009).  Under starvation or rapamycin-treated conditions, mTORC1 
no longer phosphorylates ULK1 (Jung et al., 2009) (Ganley et al., 2009; Hosokawa et al., 
2009a).  In this state, ULK1 appears to be more active in its kinase activity.  S318 in 
Atg13 has been identified as a phosphorylation site by ULK1 (Joo et al., 2011).  The 
phosphorylation was found to be important for Parkin-induced mitophagy. 
Another key regulator of ULK1 is AMPK, a serine/threonine protein kinase 
ubiquitiously expressed and highly conserved in eukaryotes. AMPK exists as a protein 
complex containing three subunits named alpha, beta and gamma (reviewed in (Hardie et 
al., 2012)).  Calcium calmodulin-dependent protein kinase kinase (CaMKK) and tumor 
suppressor STK11/LKB1 regulate the activity of AMPK.  They phosphorylate Thr172 of 
AMPK alpha catalytic subunit and activate AMPK (Hawley et al., 2003; Hong et al., 
2003; Woods et al., 2003). CaMKK and LKB1 are activated by intracellular calcium 
levels and the AMP:ATP ratio (Hong et al., 2003).  A recent study showed that 
mitochondrial uptake of Insp3R-released calcium is fundamental for oxidative 
phosphorylation and ATP production (Cardenas et al., 2010).  Reduction of this calcium 
uptake results in reduced ATP production and activation of AMPK. The AMPK activity 
is also regulated by circulating hormones and cytokines, including bradykinin and the 
adipokines leptin and adiponectin through unknown mechanism (Xu et al., 2012).  
Pharmaceutical reagents like the anti-diabetic metformin, thiazolidinediones and 
peroxisome proliferator-activated receptor alpha (PPAR-) agonist fenofibrate also 
activate AMPK through unknown mechanism (Gruzman et al., 2009). 
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AMPK can indirectly induce autophagy through inhibiting mTORC1. AMPK 
phosphorylates and activates TSC2, the inhibitor of mTORC1, thus resulting in 
suppression of mTORC1 (Inoki et al., 2003b).  AMPK also phosphorylates raptor at 
Ser722 and Ser792 resulting in inhibition of mTORC1 (Gwinn et al., 2008).  
AMPK also directly phosphorylate ULK1 to induce autophagy (Egan et al., 2011; 
Kim et al., 2011; Shang et al., 2011).  The phosphorylation was shown to be required for 
the activation of ULK1 in macroautophagy and mitophagy induction (Egan et al., 2011; 
Kim et al., 2011).  The association of AMPK with ULK1 results in multiple 
phosphorylations of ULK1 by AMPK on Ser317, Ser467, Ser555, Thr575, Ser638 
(Ser637 in mouse) and Ser777 (Egan et al., 2011; Kim et al., 2011). Dephosphorylation 
of ULK1 by mTOR at Ser758 and phosphorylations by AMPK on S317, S555, and S777 
appear to be important for the activation of ULK1 for autophagy induction.  The binding 
and phosphorylation of ULK1 by AMPK is prevented by mTORC1-mediated 
phosphorylation of ULK1 (Egan et al., 2011; Kim et al., 2011). This way mTOR and 
AMPK counteract to control autophagy induction (Figure 6). mTOR regulates ULK2 in a 
similar pattern as ULK1 (Chan et al., 2009; Hosokawa et al., 2009a; Jung et al., 2009) but 
the regulation of ULK2 by AMPK remains to be determined. 
Like yeast PKA, mammalian PKA regulates autophagy via Atg1/ULK1.  
However, the regulator mode is different.  In mammalian cells, PKA activates mTORC1 
(Mavrakis et al., 2006) and it appears to involve phosphorylation of PRAS40 by PKA 
(Blancquaert et al., 2010) or phosphorylation and inactivation of AMPK by PKA 
(Djouder et al., 2010). 
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Figure 6. Regulation of ULK1 in mammals.   
(a) The ULK1 complex is inactive under nutrient-enriched conditions. AMPK does not 
interact with ULK1 and mTOR phosphorylation of ULK1 inhibits the ULK1 complex 
(Hosokawa et al., 2009a; Jung et al., 2009). PKA activates TORC1 (Mavrakis et al., 
2006) and it can also phosphorylate and inactivate AMPK (Djouder et al., 2010). 
(b) The ULK1 complex is active under nutrient-starved conditions. Inactive mTOR 
disassociates from the ULK1 complex. AMPK binds to ULK1 and phosphorylates ULK1 
to activate it (Egan et al., 2011; Kim et al., 2011). The "P" sign for phosphorylation is 
shown in the same color as the kinase responsible for the phosphorylation. Arrows 
pointing to the "P" sign indicate activating phosphorylation, and blunted lines pointing to 
the "P" sign indicate inhibiting phosphorylation. 
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e.         How the ULK1 complex regulates autophagy.  
The ULK1 complex was originally found to function at the initial stage of 
autophagy, but it has also been shown to regulate other stages of autophagy (Figure 5).  
Under nutrient rich conditions,  ULK1 is located in dispersed area in the cytoplasm, while 
in conditions favoring autophagy induction ULK1 is re-distributed to form puncta on the 
ER (Itakura and Mizushima, 2010). The ULK1 puncta colocalizes with Atg14L, Atg16L 
and WIPI-1, and localizes adjacently to DFCP1 (Itakura and Mizushima, 2010).  These 
proteins localize to the isolation membrane or elongating isolation membranes (Fujita et 
al., 2008; Matsunaga et al., 2010; Polson et al., 2010), suggesting that ULK1 is localized 
to the isolation membrane.  Kinase-dead forms of ULK1 and ULK2 are able to localize to 
the isolation membrane in mammalian cells (Matsunaga et al., 2010; Matsunaga et al., 
2009). This suggests that the localization of ULK1/2 to the isolation membrane does not 
depend on the kinase activity of ULK1/2.  The formation of the isolation membrane was 
suppressed in FIP200-deficient MEFs (Itakura and Mizushima, 2010), suggesting that the 
integrity of the ULK1 complex is required for the formation of the isolation membrane.  
Another key component involved in the formation of isolation membrane is the 
Atg14L-containing PI3KC3 complex that is responsible for the production of PI3P on the 
ER membrane (Matsunaga et al., 2009; Zhong et al., 2009).  The PI3KC3 complex 
recruits DFCP1 and WIPI family proteins to the site where the isolation membrane 
formation is initiated (Axe et al., 2008; Matsunaga et al., 2010; Polson et al., 2010). In 
Drosophila, Atg1 regulates PI3P localization to autophagosome upon starvation (Juhasz 
et al., 2008).  Similarly, in mammalian cells ULK1 is required for the formation of 
Atg14L puncta (Itakura and Mizushima, 2010). ULK1 puncta could still be formed in 
cells treated with wortmannin, the inhibitor of PI3KC3, suggesting that the ULK1 
complex might function upstream of the PI3KC3 complex (Itakura and Mizushima, 
2010).  Although these studies have supported the stimulatory function of ULK1 on 
Atg14L-PIKC3 complex, it has not been directly demonstrated that ULK1 regulates the 
activation of Atg14-containing PI3KC3 complex. A recent finding of the Exocyst 
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complex in the autophagy pathway introduces another tilt in the mechanism of Atg14L-
PI3KC3 complex activation with respect to the function of ULK1 in the activation of 
PI3KC3 and autophagy induction (Bodemann et al., 2011).  In this study, a Ras-like small 
G protein, RalB, was found to interact with its effector Exo84 in the Exocyst complex.  
Through the interaction, RalB induces the assembly of ULK1 complex and Atg14L-
Beclin 1-PI3KC3 complex on the Exocyst (Bodemann et al., 2011). 
During the elongation and maturation steps of the autophagosome formation in 
yeast, Vps34 plays an important role in the recruitment of Atg5-Atg12 conjugation 
complex to PAS in yeast (Suzuki et al., 2001). Although this finding supports the 
possibility that Atg1/ULK1 functions upstream of Atg5, the localization of ULK1/2 to 
the isolation membrane has been shown to depend on Atg5 (Hara et al., 2008).  Thus, it 
appears that ULK1/2 and Atg5 are inter-dependent during the formation of the isolation 
membrane.  A recent study, however, provides a different view on the inter-relationship 
between ULK1/2 and Atg5 by providing evidence that autophagy can be induced 
independently of Atg5/Atg7 but dependently of ULK1 (Nishida et al., 2009). This 
implies that there might exist multiple types of autophagy in mammalian cells.  The PE-
conjugated Atg8 homologues, such as LC3, GATE16 and GABARAP, are important for 
the autophagic membrane elongation (Weidberg et al., 2010). The yeast Atg1 interacts 
with Atg8 through an Atg8 interacting motif (AIM), through which Atg1 interacts with 
the isolation membrane (Nakatogawa et al., 2012). This interaction is important for Atg1 
localization to the isolation membrane. Similarly, ULK1 interacts with Atg8 proteins 
such as GATE16 and GABARAP via an LC3-interaction region (LIR) (Kraft et al., 2012; 
Okazaki et al., 2000) . 
ULK1 also plays an important role in the regulation of Atg9 function during the 
membrane elongation process.  Atg9 shuttles between TGN and other membrane 
compartments in the cytoplasm.  This shuttling was proposed to play an important role in 
recruiting membrane fractions to the isolation membrane formation (Orsi et al., 2012).  
ULK1 knockdown in HEK293 cells interfered with the proper shuttling of Atg9 (Young 
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et al., 2006).  A recent study has shown that Atg1/ULK1 phosphorylates and activates 
spaghetti-squash activator  (Sqa) in Drosophila or zipper-interacting protein kinase 
(ZIPK, also known as DAPK3) in mammalian cells under starvation (Tang et al., 2010).  
Sqa and ZIPK belong to the DAPK serine/threonine protein kinase family.  The activated 
DAPK in turn phosphorylates myosin II regulatory light chain to activate myosin, the 
motor protein moving on the actin filaments and driving the trafficking of Atg9-
containing membranes. Through the process, Atg9 trafficking from the TGN to the 
isolation membrane can be regulated by ULK1 (Tang et al., 2010).  Another interesting 
finding is that mammalian Atg9 has a similar sub-cellular distribution as WIPI-2, an 
effector of PI3P (Jeffries et al., 2004).  WIPI-2 is one of the human counterparts of yeast 
Atg18. In yeast, Atg9 interacts with Atg18 in a manner dependent upon Atg1 (Reggiori et 
al., 2004). Thus, Atg1/Ulk1 appears to regulate Atg9 through multiple pathways.  
However, a recent study has shown that the Atg9 shuttling could happen independently of 
ULK1 (Orsi et al., 2012).   Thus, further studies are necessary to clarify the role of ULK1 
in the regulation of Atg9. 
   
f.         Non-autophagic functions of ULK1. 
Although the major functions of ULK1 and ULK2 are related to autophagy 
regulation, they were shown to regulate cellular processes that are not directly linked to 
autophagy.  In C. elegans, Unc-51 was first characterized for regulating outgrowth of 
mouse neurons (Tomoda et al., 1999). Loss of Unc-51 function resulted in axonal 
elongation defects and thus an uncoordinated phenotype (Ogura et al., 1994).  (Ogura et 
al., 1994).  Loss of other autophagy genes, such as epg-1 (homolog of Atg13 ) in C. 
elegans, did not yield this phenotype (Tian et al., 2009).  This suggests a unique role of 
Unc-51 in neuronal development (Ogura and Goshima, 2006; Tian et al., 2009).  The role 
of Unc-51 in axonal elongation may be attributed to its interaction with Unc-14 (Ogura et 
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al., 1997) and VAB-8L (Lai and Garriga, 2004). In Drosophila, Atg1 plays an important 
role in axonal transport through its binding with Unc-76 (Toda et al., 2008).  
ULK1 was shown to interact with paxillin (Chen et al., 2008), SynGAP, syntenin 
(Tomoda et al., 2004), and TrkA/NGF receptor/p62 (Zhou et al., 2007).  The interaction 
between ULK1 and TrkA/NGF receptor/p62 has been shown to be important for the 
endocytic processes (Zhou et al., 2007).  The binding of ULK1 to SynGAP, syntenin and 
TrkA/NGF receptor/p62 suggests a role of ULK1 in filopodia extension and axon 
branching (Tomoda et al., 1999; Tomoda et al., 2004; Zhou et al., 2007).  FIP200, as a 
component of the ULK complex, interacts with stathmin, Pyk2, FAK, p53, TSC1, ASK1, 
and TRAF2 (Gan and Guan, 2008).  Although it is unclear whether these proteins also 
interact with ULK1 and Atg13, it is possible that ULK1/2 may be involved in processes 
other than autophagy through FIP200 and its binding proteins.   
The Atg1/Ulk1 complex appears to function not only as a downstream effector of 
mTORC1 but also as an upstream effector of mTORC1.  In Drosophila, Atg1 was shown 
to negatively regulate TORC1 signaling (Scott et al., 2007).  Both ULK1 and ULK2 were 
also shown to negatively regulate mTORC1 signaling in mammalian cells (Dunlop et al., 
2011; Jung et al., 2011; Lee et al., 2007b). A recent study has shown that ULK1 
promoted phosphorylation of raptor at Ser855, Ser859, and Ser792 (Dunlop et al., 2011).  
ULK1 over-expression increased the phosphorylation of raptor at Ser863 and the 
phosphorylation of mTOR at Ser2481 (Dunlop et al., 2011).  Overexpression of ULK1 
inhibited the phosphorylation of mTORC1 substrates, S6K1 and 4E-BP1 and it inhibits 
the binding of raptor with 4E-BP1 (Dunlop et al., 2011; Jung et al., 2011). These findings 
suggest that TOR and Atg1/Ulk intimately crosstalk for optimal coordination of  the 
cellular processes involving cell growth and autophagy.  ULK1 was also shown to 
phosphorylate the three subunits of AMPK and (Loffler et al., 2011).  Although the 
functional consequence of the phosphorylations remains unclear, the phosphorylations 
appear to negatively regulate the activity of AMPK.  Thus, ULK1 may induce the 
termination of the autophagy processes by inhibiting AMPK to prevent an excessive 
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autophagy. Further studies are necessary to clarify this regulatory mechanism and the 
physiological significance of this potential regulation. 
 
g.        Missing gaps in the regulation of the ULK1 complex.  
As summarized above, the ULK1 complex participates in the early steps of the 
isolation membrane formation. However, the molecular mechanisms remain unclear. In 
particular, how ULK1 is recruited and activated to the site of the isolation membrane 
formation in the first place remains poorly understood. My thesis work has aimed to 
better understand the mechanisms of the Ulk1 complex and led to a discovery of a novel 
component of the complex , which is named MCF.2 cell line derived transforming 
sequence-like 2 (MCF2L2).  Because this protein has an implicated function in the 
regulation of actin cytoskeleton, my work has involved characterization of the function of 
this protein in cytoskeletal regulation.  Importantly, the role of actin cytoskeleton in 
autophagy process remains barely understood.  Below, I have briefly introduced the 
critical information on actin cytoskeletal regulation related to my study and how actin 
cytoskeleton could play a role in autophagy process. 
 
IV.       Cytoskeleton proteins in autophagy 
The roles of cytoskeletal proteins in autophagy induction remains poorly 
understood.  There are several studies supportive of the important roles of actin 
cytoskeletal proteins in the regulation of autophagy induction (Monastyrska et al., 2008; 
Zhu et al., 2011).  One study showed that F-actin was reported to form at the site of 
autophagosome-lysosome fusion (Lee et al., 2010b), and the formation of F-actin (actin 
nucleation) is subject to regulation of Rho GTPase guanine nucleotide exchange factor 
(GEF). In addition, the yeast Atg9 interacts with actin nucleation factor Arp2 during its 
trafficking between Golgi, endosome and PAS (Monastyrska et al., 2008), and therefore 
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presents a potential connection between actin nucleation and the autophagy pathway. As 
mentioned above, Atg1/ULK1 phosphorylates and activates Sqa in Drosophila and ZIPK 
in human, which in turn phosphorylate myosin II regulatory light chain to activate 
myosin.  Myosin is regulated by Rho-GTPase effector—Rho-associated kinases (ROCK), 
and it acts as a cargo carrier for Atg9 in the membrane cycle. The following section will 
briefly introduce the current knowledge on Rho GTPases, which is an important player in 
both actin nucleation and myosin regulation. 
 
a. Rho-GTPases 
The family of Rho GTPases controls a wide variety of signal transduction 
pathways in eukaryotes.  The major functions include the regulation of the actin 
cytoskeleton, cell polarity, microtubule dynamics, membrane transport pathways and 
transcription factor activity (reviewed in (Etienne-Manneville and Hall, 2002)).  The 
GTPases cycle between the two exchangeable states: the GTP-bound active form and the 
GDP-bound inactive form.  The GTP-bound active state of GTPases elicits response in 
target proteins.  The hydrolysis of GTP to GDP inactivates GTPases.  Rho GTPase 
belongs to the Ras GTPase superfamily, which falls into five major groups: Ras, Rho, 
Rab, Arf and Ran.  The human genome contains over 60 activators (GEF) and over 70 
inactivators (GAP) for the Rho family GTPases. The Rho-, Rac- and Cdc42-GTPases are 
the three best-characterized members of the Rho GTPase family, and so far there are over 
60 targets identified for these three GTPases (Etienne-Manneville and Hall, 2002). The 
following sections will elaborate on two pathways that have a possible linkage with the 
autophagy machinery. 
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b. Actin nucleation 
Actin is one of the most abundant and highly-conserved proteins in eukaryotes. 
Globular (G)-actin is a 42 kDa monomeric ATP-binding protein, and it can be converted 
into filamentous (F)-actin through polymerization (also called nucleation).  The actin 
filaments create structural scaffolds and support, and serve as tracks for motor proteins. 
The first major actin nucleator identified was the Arp2/3 complex, a 220 kDa factor made 
of seven stably-associated polypeptides which are highly conserved in almost all 
eukaryoteic organisms.  Purified Arp2/3 complex showed the ability to bind to the side of 
an existing actin filament in vitro (Welch et al., 1997). Arp2 and Arp3 dimerize at an 
angle as the first two subunits of a de novo filament. The addition of new actin molecules 
continues at a Y-branch angle based on the existing filament (Goley and Welch, 2006). 
The Arp2/3 complex sits on the pointed end of nascent filament as a cap, allowing 
the barbed end to elongate freely. ATP binds to Arp2 and the hydrolysis of ATP provides 
the driving force for both actin nucleation and debranching (Dayel and Mullins, 2004; 
Goley et al., 2004; Zencheck et al., 2009). 
Purified Arp2/3 complex only contains very little catalyzing efficiency, and its 
binding to the actin filaments enhances the activity of Arp2/3 (Nolen et al., 2004). 
Several more factors are required for potent actin polymerization including 
phosphorylation of threonine and tyrosine residues in Arp2 (LeClaire et al., 2008), and 
more critically, the engagement of WCA domain-containing proteins encoded by 
microbial pathogens or the mammalian nucleation-promoting factors (NPFs) complex 
(Goley and Welch, 2006).  
The WCA domain is comprised of one or several WASP-homology (WH) motifs 
binding to actin monomers, together with an amphipathic connector region and acidic 
peptides collectively binding the Arp2/3 complex. Class I mammalian NPFs are a huge 
family of proteins with WCA domains at the C-terminus and are subcategorized into five 
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groups based on the N-terminal sequences: (1) the WASP (originally named after the 
Wiskott-Aldrich Syndrome protein) and N-WASP superfamily, (2) three WAVE (WASP-
family verprolin homolog) isoforms, and three more recently identified categories: (3) 
WASH (WASP/Scar homolog), (4) WHAMM (WASP homolog associated with actin, 
membranes and microtubules), and (5) JMY (junction-mediating regulatory protein) 
(Kurisu and Takenawa, 2009; Stradal and Scita, 2006). 
Linear actin filament networks enhance the rate of filament formation and solidify 
the filament organization. The nucleation in these processes is regulated by WASH 
together with other nucleators (Chhabra and Higgs, 2007; Wang and Riechmann, 2008). 
Rho1 in the Rho family of small GTPases is a key regulator upstream of WASH in the 
linear actin filament formation (Goode and Eck, 2007).  WASP and WAVE are regulated 
by the Rho GTPases Cdc42 and Rac, respectively (Liu et al., 2009b), and they are 
required for the branched actin filament activities (Stradal et al., 2004; Takenawa and 
Suetsugu, 2007). WH1 domain in WASP and N-WASP is linked to the GTPase 
binding/Cdc42 and Rac interactive binding domain, which physically interacts with the 
Rho small GTPase Cdc42 (Pollitt and Insall, 2009).  
 
c.       ROCK-myosin pathway 
Another mechanism through which Rho GTPases might regulate autophagy 
involves the regulation of myosin by ROCK.  There are two ROCK isoforms:  ROCK1 
(ROKβ, p160ROCK) and ROCK2 (ROKα). ROCK1 and ROCK2 share 65% homology 
in the entire amino acid sequence and 92% homology in the kinase domains. The two 
isoforms are both ubiquitously expressed, while ROCK1 expression is enriched in lung, 
liver, spleen, kidney, and testis, and ROCK2 is enriched in the brain and heart (Nakagawa 
et al., 1996).  
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ROCK is a major downstream effector of the small GTPase RhoA with its C-
terminal coiled coil domain specifically interacting with RhoA (Hahmann and Schroeter, 
2010; Matsui et al., 1996). The downstream substrates for ROCK include myosin light 
chain (MLC), MLC phosphatase, ezrin/radixin/moesin, adducin, and LIM kinases, all of 
which are modulators of actin cytoskeletal organization, stress fiber formation and cell 
contraction (Nakagawa et al., 1996). The N-terminal serine-threonine kinase domain of 
ROCK phosphorylates MLC (Leung et al., 1996), which regulates the movement of 
myosin on actin filaments (Nakagawa et al., 1996). MLC was found to be involved in 
ULK1-regulated autophagic membrane trafficking (Tang et al., 2010). These findings 
indicate ULK1 may regulate the autophagosome formation through the Rho GTPase-
ROCK-MLC signaling pathway. 
 
V.       Summary 
In summary, autophagy is a well conserved cellualr degradation pathway engaged 
in a variety of physiological and pathological conditions. The induction of autophagy in 
response to nutrition, stress and growth factor regulation is mediated by the ULK1 
complex, but the exact mechanism remains unknown. My thesis has aimed to understand 
the regulation of ULK1 in autophagy. 
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CHAPTER 2. RESULTS 
I.          Discovery of MCF2L2 as a novel binding protein of the ULK1 complex 
a.         Yeast two-hybrid screen identified MCF2L2 as a binding protein of Atg13 
To understand how the ULK1 complex regulates the induction of autophagy, we 
sought to identify other components of the ULK1 complex.  According to protein elution 
analysis in literatures, ULK1 and Atg13 were eluted at a molecular size of 1-3 MDa 
(Hosokawa et al., 2009a; Mizushima, 2010).  Furthermore, several proteins are known as 
components of the yeast Atg1 complex  (Funakoshi et al., 1997; Kabeya et al., 2009), 
while their corresponding homologues have not been clearly defined in mammalian cells. 
In order to search for unknown components in the ULK1 complex, we performed 
a yeast two-hybrid screen using a human fetal brain cDNA library with Atg13 as bait. We 
performed two rounds of screens with low and high stringency and obtained four positive 
hits (Figure 7).  The four positive hits included ULK1, suggesting that the yeast two 
hybrid screen was valid to identify binding partners of Atg13.  Two other hits were 
GATE16 and GABARAP, the LC3-related mammalian homologues of Atg8. A previous 
study has shown that GATE16 and GABARAP interact with ULK1 (Okazaki et al., 
2000), which is consistent with our finding that they are Atg13-binding proteins.  
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  Figure 7. Yeast two-hybrid screening identified 4 potential binding partners of 
Atg13.  
Eleven clones that were selected from a low-stringent screen were tested under a 
high stringent condition to confirm the interaction with Atg13.  The yellow-colored boxes 
indicate the four positive clones of Atg13-binding proteins that have grown under a high 
stringent condition (see Materials and Methods section).  The clones are: #6, GATE16; 
#7, GABARAP; #15, ULK1; #23, MCF2L2.   Each clone was tested for its growth in the 
presence of the bait (labeled by “B”, which is Atg13) or absence of the bait (labeled by 
“V”, which is vector alone). 
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The fourth clone contained part (amino acids 540-768) of a gene named MCF2L2.   
Its predicted full length cDNA encodes a protein of 127 kDa with 1114 amino acids.  
MCF2L2 does not share sequence similarity with any yeast autophagy proteins.  
MCF2L2 shows 46% of sequence identity and has virtually the identical domains with 
another protein named MCF2L.  MCF2L is also called Dbs (Dbl's big sister), Ost or Rho 
guanine nucleotide exchange factor-14 (ARHGEF14).  Both MCF2L2 and MCF2L are 
homologous to MCF2 that is also called Dbl (Figure 8a and b). The MCF2L2 gene exists 
in higher vertebrates, such as human, chimpanzee, cow, but not found in rodents like 
mice and rat according to the NCBI protein database (Figure 8c).  Interestingly, MCF2L2 
gene was also found in chicken, which are at a lower position in the evolution tree than 
the rodents (Figure 8c).  The MCF2L and MCF2 gene are conserved in a more complete 
spectrum of vertebrate species from mouse to human, but MCF2 has not been reported in 
Chimpanzees (Figure 8c).  Both MCF2 and MCF2L is known to regulate the small Rho 
GTPases such as RhoA, Rac1, and CDC42 (Ieguchi et al., 2007).  All of these three 
proteins have four domains: Sec14p-like lipid-binding domain (SEC14); Spectrin repeat 
motifs (SPEC); RhoGEF domain (or Dbl-homologous (DH) domain; Dbs plecstrin 
hommology (PH) domain (PH_Dbs) or PH like domain.  The SEC14 domain is found in 
secretory proteins and in lipid regulated proteins such as RhoGAPs and RhoGEFs and it 
is known to associate with G protein / subunits (Aravind et al., 1999).  The SPEC 
domain is often found in proteins involved in cytoskeletal organization such as spectrin 
and -actinin and dystrophin (Broderick and Winder, 2005), and MCF2L2 shares about 
50% sequence homology with MCF2K in the domain. The spectrin repeat forms a three-
helix bundle (Viel, 1999). The DH domain is invariably present at the N-terminal to the 
PH domain (Cerione and Zheng, 1996).  The PH domain of MCF2 and MCF2L 
participates in binding to both the Cdc42 and RhoA GTPases (Ieguchi et al., 2007; 
Whitehead et al., 1999). The specificity of the PH domain is usually determined by the 
loop regions or insertions at the N-terminal region (Fuentes et al., 2003). The N-terminal 
regions of the PH domain in MCF2, MCF2L and MCF2L2 are highly conserved (Figure 
8b). 
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While MCF2L is known to regulate small Rho GTPases such as RhoA, Rac1, and 
CDC42 (Ieguchi et al., 2007), MCF2L2 has not been studied at all for its function.  There 
have been three publications as of August 31, 2012 in the NCBI PubMed database about 
the MCF2L2 gene and its variants linked to obesity- and polycystic ovary syndrome 
(PCOS) (Takeuchi et al., 2008; Zhang et al., 2010; Zheng et al., 2009a).  This interesting 
relationship of MCF2L2 gene to the metabolic diseases has not been explored at all.  
Since MCF2L2 has been identified as a potential binding protein of Atg13, it is possible 
that MCF2L2 would affect metabolism through the autophagy process.  My thesis work 
has been focused on confirming the interaction between Atg13 and MCF2L2 and 
determining the functions of MCF2L2 in the regulation of autophagy. 
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Figure 8. MCF2L2 belongs to the Dbs-related Rho GEF family.  
(a) The 3 MCF2L2 homologues contain 4 domains: 
SEC14, sec14p-like lipid-binding domain; SPEC, spectrin repeats (SPEC); Rho-GEF, 
guanine nucleotide exchange factor for Rho/Rac/Cdc42-like GTPases; PH_Dbs, Dbl's big 
sister (Dbs) pleckstrin homology (PH) domain. 
(b) The Rho-GEF domain and the PH_Dbs or PH like domains are highly conserved 
between MCF2L2, MCF2L and MCF2.  
Sequence alignment was made using Multalin program (http://expasy.org/tools/). Primary 
consensus are listed below the individual  sequences.  
(c) MCF2L2 gene has not been found in mouse and rat genomes but in chicken, dog, 
cow, chimpanzee and human genomes  (NCBI homologene database).   
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b.         MCF2L2 interacts with the ULK1 complex. 
To confirm the result of the yeast two hybrid screen, I first cloned the full length 
cDNA of MCF2L2 into prk5-HA mammalian expression vector by PCR amplification. 
For this, we obtained KIAA0860 and BC064632 clones from Kazusa DNA Research 
Institute in Japan and Open Biosystems and used them as templates for the PCR cloning.  
These two clones were missing 5’- and 3’-ends of the full length cDNAs, respectively.  
Thus, I designed a cloning strategy to combine the two clones using a XhoI site in the 
middle shared by the two clones.   The full-length cDNA of MCF2L2 gene with 3,349 
nucleotides was successfully cloned in the vector and confirmed by sequencing. The 
cloned full length cDNA was transferred into multiple other expression vectors, including 
pEGFP-C3, pGEX6P2, and myc-prk5 vectors. 
In order to determine if MCF2L2 interacts with Atg13, HEK293T cells were 
transiently transduced with plasmids encoding myc-MCF2L2 and HA-tagged Atg13.  I 
also included HA-tagged ULK1 to test if MCF2L2 can also interact with ULK1.  As 
negative controls, HA-tagged S6K1 and phosphatidic acid-preferring phospholipase A 
(PA-PLA) were used.  S6K1 and PA-PLA are cytosolic and membrane-bound proteins, 
respectively. Forty-eight hours post-transfection, cell lysate was obtained and 
immunoprecipitation was conducted using anti-myc antibody. Immunoprecipitated 
complexes were run on a SDS-PAGE and analyzed by Western blotting.   Both HA-
tagged ULK1 and Atg13 were detected in the immunoprecipitate isolated with myc-
tagged MCF2L2 (Figure 9a). I could not detect any control protein immunoprecipitated 
with myc-MCF2L2.  I also tested FIP200, another component of the ULK1 complex, for 
its interaction with MCF2L2.  For this experiment, I included multiple negative control 
proteins, such as S6K1, hVps34, raptor and PRAS40, as well as Atg13.  HA-MCF2L2 
was co-immunoprecipitated with myc-tagged FIP200 and Atg13 but not with the negative 
control proteins (Figure 9b).  Combined, these results suggest that MCF2L2 interacts 
with the ULK1 complex. 
 50 
 
To confirm if the interaction can occur between endogenous proteins, we 
generated polyclonal antibodies against human MCF2L2.  The C-terminal fragment of 
MCF2L2 containing amino acids 250-1129 was expressed as a N-terminal glutathione S-
transferase (GST)-fusion form in bacteria and purified through GSH affinity column.  
The purified fragment was used to generate polyclonal antibodies in rabbit.  The 
generated antibody was confirmed to recognize endogenous MCF2L2 specifically 
(Figure 9c). 
To confirm the interaction between endogenous proteins using the antibody, 
Atg13 immunoprecipitate was obtained using anti-Atg13 antibody from HEK293T cells 
and the presence of MCF2L2 in the immunoprecipitate was analyzed by Western 
blotting.  As a control, pre-immune serum was used instead of Atg13 antibody.  MCF2L2 
was detected with the immunoprecipitate obtained using anti-Atg13 antibody but not pre-
immune serum (Figure 9d).  Inversely, ULK1 and Atg13 were detected in immune 
complex obtained using anti-MCF2L2 antibody but not pre-immune serum (Figure 9e). 
Collectively, these results suggest that MCF2L interacts with the ULK1 complex at 
recombinant and endogenous levels. 
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Figure 9. MCF2L2 interacts with ULK1, Atg13 and FIP200.    
(a)   ULK1 and Atg13 are coimmunoprecipitated with MCF2L2. 
HA-tagged ULK1 or Atg13 was expressed with myc-tagged MCF2L2 or control proteins 
(S6K1 and PA-PLA as negative controls, and Atg13 or ULK1 as positive control) in 
HEK293T cells. Anti-myc immune complexes were assessed for the presence of HA-
ULK1 and HA-Atg13 by Western blotting. 
(b)   MCF2L2 binds ULK1, Atg13 and FIP200. 
HA-tagged MCF2L2 was expressed with myc-tagged ULK1, Atg13, FIP200 or control 
proteins (hVps34, raptor, PRAS40) in HEK293T cells. Anti-myc immune complexes 
were assessed for the presence of HA-MCF2L2 by Western blotting.  
(c)   MCF2L2 antibody specifically binds to endogenous MCF2L2 . 
HEK293 cells were transduced with sh-RNA for MCF2L2 or scramble as control. Cell 
lysate was assayed by Western blotting for the presence of MCF2L2 (~127 kD) with 
MCF2L2 antibody. 
(d)   Endogenous MCF2L2 is coimmunoprecipitated with Atg13. 
Atg13 immunoprecipitate using anti-Atg13 serum was obtained from HEK293T cells and 
the amounts of MCF2L2 in the immune complexes were assayed by Western blotting. 
Atg13 pre-immune serum immunoprecipitate was assayed as  negative control. Atg13 
immunoprecipitate using anti-Atg13 antibody was obtained from HEK293T cells too and 
the amounts of MCF2L2 in the immune complexes were assayed by Western blotting. 
Glut4, rictor, and mTOR antibodies were used as negative controls.  
(e)   Endogenous ULK1 and Atg13 interact with MCF2L2.  
MCF2L2 immunoprecipitate was obtained from HEK293T cells and the amounts of 
ULK1 and Atg13 in the immune complexes were assayed by Western blotting. MCF2L2 
pre-immune serum immunoprecipitate was assayed as  negative control.  
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c.       MCF2L2 directly binds to Atg13 independently of ULK1. 
The background section introduced that ULK1 is a multi-functional protein with 
its role not limited to autophagy.  Its N-terminal region contains a kinase domain while 
the C-terminal region interacts with different binding partners.  When interacting with 
Atg13, ULK1 was found to function in autophagy, while when interacting with other 
proteins, ULK1 may switch to function in neuronal regulation (Lai and Garriga, 2004; 
Ogura et al., 1997). Therefore, it is important to determine if MCF2L2 binds to ULK1 
through Atg13 so it functions in autophagy pathway. 
To determine if the interaction between Atg13 and MCF2L2 depends on ULK1, I 
analyzed the interaction in ULK1-deficient MEFs.  Since MEFs do not express MCF2L2, 
I transiently expressed HA-MCF2L2 in MEFs. I isolated immune complex using anti-
Atg13 antibody and analyzed the amount of MCF2L2 in the immune complex.  MCF2L2 
was still detected in the anti-Atg13 immune complex isolated from ULK1-deficient 
MEFs (Figure 10a), suggesting that Atg13 can bind to MCF2L2 independently of ULK1.  
Next, I used Atg13-silenced HEK293T cells to determine if Atg13 is important for the 
interaction between MCF2L2 and ULK1. Knockdown of Atg13 in HEK293T cells almost 
completely abolished the interaction between ULK1 and MCF2L2 (Figure 10b).  This 
result suggests that Atg13, but not ULK1, is important for the binding of MCF2L2 to the 
ULK1 complex.  The dependence of the interaction on Atg13 implies that MCF2L2 
might participate in autophagy rather than non-autophagic functions mediated by ULK1. 
 
d.        N-terminal region of MCF2L2 binds to a C-terminal region of ULK1 through 
Atg13. 
To better understand how MCF2L2 interacts with the ULK1 complex, I 
conducted a delimitation experiment to identify the region of MCF2L2, Atg13 and ULK1 
involved in the interaction.  It is known that ULK1 interacts with Atg13 via its C-terminal 
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region (Hosokawa et al., 2009b). Since Atg13, but not ULK1, binds to MCF2L2, I 
predicted that MCF2L2 might bind to the C-terminal region of ULK1 where Atg13 binds. 
As predicted, I found that MCF2L2 binds to the C-terminal region of ULK1 containing 
amino acid residues 651-1051 (Figure 10c).  The binding of MCF2L2 to the C-terminal 
region of ULK1 further confirms that MCF2L2 binds to ULK1 via Atg13.  I found that 
all the fragments of Atg13 can interact with MCF2L2 (Figure 10d). A possible 
explanation might be that Atg13 might require its whole sequence for binding to 
MCF2L2 or multiple regions of Atg13 might be involved in the interaction with MCF2L2.  
I also performed a delimitation experiment to determine which region(s) of MCF2L2 are 
involved in the interaction of MCF2L2 with Atg13.  I found that Atg13 binds to a N-
terminal region of MCF2L2 within amino acids 1-500 (Figure 10e). 
To confirmed if MCF2L2 and Atg13 directly interact with each other, I attempted 
to purify MCF2L2 from bacteria.  Since the full length MCF2L2 was not able to be 
purified in a soluble form, we purified its fragments.  Knowing that the N-terminal region 
of MCF2L2 interacts with Atg13 (Figure 10e), I expressed and purified N-terminal 
fragments of MCF2L2 and successfully obtained their soluble forms.  Through GSH pull 
down experiment using the purified fragments, I confirmed that MCF2L2 can interact 
with Atg13 in vitro (Figure 10f).  Collectively, these results suggest that a N-terminal 
region of MCF2L2 directly interacts with Atg13.  
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Figure 10. Atg13 directly binds to MCF2L2.  
(a)   MCF2L2 can interact with Atg13 in the absence of ULK1.  
HA-tagged MCF2L2 was expressed in ULK1 deficient (-/-)  or wild type (+/+)  MEFs. 
Anti-Atg13 immune complexes were obtained and analyzed for the presence of HA-
MCF2L2 by Western blotting. 
(b)   Atg13 is necessary for the interaction between ULK1 and MCF2L2. 
ULK1 immunoprecipitate was obtained from HEK293T cells transduced with either 
scrambled shRNA or Atg13 shRNA.  The amount of MCF2L2 in the ULK1 immune 
complex was analyzed by Western blotting. 
(c)   MCF2L2 interacts with ULK1 C-terminal region. 
Myc-tagged fragments of ULK1 were coexpressed with HA-tagged MCF2L2 in 
HEK293T cells.  The amount of HA-MCF2L2 in myc immunoprecipitate was analyzed 
on Western blots. 
(d)   MCF2L2 requires the entire region of Atg13 for binding. 
Myc-tagged fragments of Atg13 were coexpressed with HA-tagged MCF2L2 in 
HEK293T cells.  The amount of HA-MCF2L2 in anti-myc immune complex was 
analyzed by Western blotting. 
(e)   Atg13 interacts with MCF2L2 N-terminal region. 
Myc-tagged fragments of MCF2L2 were coexpressed with HA-tagged Atg13 in 
HEK293T cells.  The amount of HA-Atg13 in myc immunoprecipitate was analyzed on 
Western blots. 
(f)   Atg13 directly interacts with MCF2L2 N-terminal regions.  
GST alone or GST-tagged MCF2L2 N-terminal fragments were incubated with 
bacterial–purified Atg13, and the amounts of Atg13 recovered with GST-tagged proteins 
were analyzed by Western blotting. 
(g)  Schematic model of the interaction between MCF2L2, ULK1 and Atg13. 
It is proposed that the N-terminal region of MCF2L2 interacts with Atg13 and binds to 
the C-terminal region of ULK1. 
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e.         MCF2L2 is a potential substrate of ULK1.   
Previous studies have shown that ULK1 phosphorylates Atg13, FIP200 and itself 
(Hosokawa et al., 2009a; Jung et al., 2009).  Thus, I tested if MCF2L2 would also be 
phosphorylated by ULK1.  Supporting this possibility, I found that wild type but not 
kinase dead mutant form of ULK1 coexpressed with HA-MCF2L2 induced a upward 
shift of HA-MCF2L2 protein band in SDS-PAGE.  The mobility shift was due to 
phosphorylation, since it was almost completely suppressed by treatment with λ 
phosphotase (Figure 11a). The induced upward shift by wild type ULK1 was shown with 
the fragments containing amino acids 500-1129 and amino acids 250-1129 but not amino 
acids 1-827 (Figure 11b).  This implies that the ULK1 phosphorylation sites in MCF2L2 
might lie in the C-terminal region containing amino acids 828-1129.   
To determine if ULK1 can directly phosphorylate MCF2L2, I conducted in vitro 
kinase assay using purified MCF2L2 fragments and immunoprecipitated ULK1 kinase as 
the enzyme source.  The In vitro kinase assay revealed that the C-terminal fragments of 
MCF2L2 can be directly phosphorylated by ULK1 (Figure 11c).  As a control, the 
kinase-dead mutant form of ULK1 did not phosphorylate MCF2L2 (Figure 11c).  
Combined, these results suggest that ULK1 has the capacity to phosphorylate MCF2L2.   
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Figure 11. ULK1 phosphorylates MCF2L2. 
(a) ULK1 induces the phosphorylation of MCF2L2. 
HA-tagged MCF2L2 was coexpressed with myc-tagged wild type (wt) or kinase dead 
(kd) mutant form of ULK1 in HEK293T cells. Myc immunoprecipitate was obtained and 
treated with or without λ phosphatase for 30 min. The migration patterns of MCF2L2 and 
ULK1 isolated from myc immunoprecipitation were analyzed on SDS-PAGE.  
(b) ULK1 induces the phosphorylation of MCF2L2 in a region near C-terminus. 
Myc-tagged MCF2L2 fragments were coexpressed with HA-tagged wt or kd mutant form 
of ULK1 in HEK293T cells. The migration patterns of MCF2L2 fragments and ULK1 
were analyzed on SDS-PAGE. 
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(c) ULK1 directly phosphorylates MCF2L2 in vitro. 
Myc-tagged wt or kd mutant form of ULK1 was isolated by myc immunoprecipitation 
from HEK293T cells and incubated with MCF2L2 C-terminal fragments purified from 
bacteria in the presence of 
32
P-ATP in vitro. The incorporation of 
32
P into ULK1 and 
MCF2L2 fragments was analyzed by autoradiography. 
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II.       MCF2L2 plays an important role in autophagy induction 
a.        MCF2L2 knockdown suppressed autophagy. 
Together with the finding that MCF2l2 directly interacts with Atg13, the finding 
that MCF2L2 is a potential substrate of ULK1 added to the evidence that MCF2L2 may 
be an essential component in the ULK1-mediated autophagy induction pathway. Previous 
studies have shown that ULK1 forms puncta structures in response to starvation (Hara et 
al., 2008; Itakura and Mizushima, 2010).  Since MCF2L2 is a component of the ULK1 
complex, I tested if MCF2L2 can also form puncta structure. In HeLa cells, GFP-tagged 
ULK1 formed puncta structures upon rapamycin treatment, and the GFP-ULK1 puncta 
co-localized with myc-MCF2L2 puncta (Figure 12a).  This result suggests that MCF2L2, 
as a component of the ULK1 complex, might participate in the formation of the ULK1 
puncta or the formation of isolation membrane (Hara et al., 2008; Itakura and Mizushima, 
2010). 
In order to better understand the function of MCF2L2 in autophagy, I have 
generated HeLa and HEK293 cells where MCF2L2 was stably silenced by lentiviral 
shRNA.  Using the stable cells, I first analyzed if MCF2L2 knockdown affects the 
autophagosome formation by staining endogenous LC3 in the shRNA-transduced HeLa 
cells.  Rapamycin for 4 hrs induced LC3-positive puncta or autophagosome in GFP 
shRNA-transduced HeLa cells (Figure 12b).  The formation of autophagosome was 
suppressed in the cells stably transduced by MCF2L2 shRNA (Figure 12b and c).  This 
result suggests that MCF2L2 is important for autophagosome formation.  To further 
confirm the role of MCF2L2 in autophagy, autophagy flux was assayed by measuring the 
levels of LC3-I and LC3-II in the presence or absence of lysosomal inhibitors.  In control 
cells, treatment of lysosomal inhibitors such as E64 and pepstatin dramatically enhanced 
the accumulation of LC3-II when cells were simultaneously treated with rapamycin 
(Figure 11d).  By contrast, MCF2L2-silenced cells did not show the prominent increase 
in LC3-II level (Figure 12d).  I also found that LC3-I, the cytosolic form of LC3, 
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accumulated in cells with MCF2L2 silenced, suggesting that the autophagy flux was 
blocked in these cells (Figure 12d). The degradation of p62 is mainly dependent upon the 
autophagy process (Mizushima and Yoshimori, 2007). I found that rapamycin treatment 
decreased the amount of p62 in control cells, whereas the decrease in p62 was suppressed 
in MCF2L2-silenced cells (Figure 11c). Combined, these results suggest that MCF2L2 is 
involved in autophagy process. 
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Figure 12. MCF2L2 is important for autophagy. 
(a) MCF2L2 forms punctual structures and co-localizes with ULK1 puncta in 
response to rapamycin. 
Twenty four hours post-transfection with GFP-tagged ULK1 and myc-MCF2L2, HeLa 
cells were treated with 100 nM rapamycin or dimethyl sulfoxide (DMSO, vehicle) for 2 
hrs. Cells were stained using myc antibody conjugated with Alexa 647 (red) and 
visualized by microscope (Olympus Fluoview 1000 IX2 inverted microscope). 
Colocalization of ULK1 puncta and MCF2L2 puncta is shown in yellow color. (Inset) 
Higher magnification demonstrates co-localization of ULK1 puncta and MCF2L2 puncta 
in rapamycin-treated cells.  Nuclei were stained with DAPI (blue). Scale bar,10 μm. 
(b) Knockdown of MCF2L2 inhibits the formation of LC3-positive autophagosomes. 
HeLa cells stably transduced by lentiviral shRNA were treated with rapamycin (100 nM) 
or DMSO for 4 hrs. Cells were stained with anti-LC3 antibody (green) and visualized by 
confocal microscope. Nuclei were stained with DAPI (blue). Scale bar,10 μm. 
(c) Quantitative analysis of GFP-LC3 puncta per cell (*p < 0.05 from Student’s t test, 
n = 15). Mean value is shown as a horizontal bar 
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(d) Knockdown of MCF2L2 inhibits rapamycin-induced autophagic flux of LC3 and 
suppresses the degradation of p62. 
HEK293T cells stably transduced by lentiviral shRNA for MCF2L2 or scramble shRNA 
were treated with rapamycin (100 nM) or DMSO for 4 h in the presence or absence of 
lysosomal inhibitors (LI), pepstatin A (10 μg/ml) and E-64 (10μg/ml), and the indicated 
proteins in cell lysates were analyzed by Western blotting.  The level of GAPDH is 
shown as loading control. 
(e) Quantification of the western blot band density for autophagy flux markers, P62, 
LC3-I and LC3-II. 
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b.     MCF2L2 acts downstream of ULK1 to regulate the production of PI3P 
essential for the formation of the isolation membrane 
Knowing that MCF2L2 is involved in autophagy, I investigated further which step 
MCF2L2 regulates in the autophagy pathway.  As explained early in the Background 
section, the ULK1 complex regulates the early step of the isolation membrane formation 
(Hosokawa et al., 2009a; Itakura and Mizushima, 2010). There are two events that were 
reported to be closely related to the ULK1 puncta formation.  First, it has been shown that 
the ULK1 complex forms punctuate structure together with the Atg14L-containing 
PI3KC3 complex upon autophagy induction (Itakura and Mizushima, 2010). I found that 
the formation of Atg14L puncta was not affected by MCF2L2 knockdown (Figure 13a).  
Thus, MCF2L2 is unlikely involved in the regulation of Atg14L puncta formation that is 
dependent upon the ULK1 complex.   
Second, the ULK1 puncta co-localize with the isolation membrane based on they 
colocalization with WIPIs, the downstream effector of PI3KC3 and markers for the 
isolation membrane (Itakura and Mizushima, 2010).  The generation of PI3P  and the 
puncta formation of WIPIs on the isolation membrane have been shown to depend on the 
ULK1 complex (Itakura and Mizushima, 2010).  I tested if MCF2L2 is important for the 
formation of WIPI-1 or ULK1 puncta using MCF2L2-silenced HeLa cells.  I found that 
the majority of WIPI-1 puncta colocalized with ULK1 puncta in GFP shRNA-transduced 
control cells. Silencing of MCF2L2 did not affect the puncta formation of GFP-ULK1, 
but disrupted the co-localization of ULK1 puncta with WIPI-1 puncta (Figure 13b and 
13c).  This result suggests that MCF2L2 might be important for the ULK1 complex to 
recruit WIPI-1 in the formation of the isolation membrane. Since MCF2L2 did not affect 
Atg14L puncta formation, the result indicates that MCF2L2 might be important for 
events downstream of the Atg14L-containing PI3KC3 complex, maybe the activation of 
PI3KC3 complex or the  recruitment and transport of WIPIs to the isolation membrane. 
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Figure 13. MCF2L2 is important for the WIPI-1 puncta formation. 
(a) Silencing of MCF2L2 does not affect the formation of Atg14L puncta. 
GFP-tagged Atg14L was expressed in HeLa cells treated with 100 nM rapamycin or 
DMSO as vehicle for 1 hr. GFP fluorescence in the cells was visualized by microscope.  
Nuclei were stained with DAPI (blue). Scale bar,10 μm. 
(b) Knockdown of MCF2L2 inhibited the co-localization of ULK1 puncta with WIPI-
1 puncta. 
GFP-tagged ULK1 and myc-WIPI-1 were co-expressed in HeLa cells. Twenty-four hrs 
post-transfection, cells were treated with 100 nM rapamycin or DMSO for 1 hr. Cells 
were immunostained using Alexa647-conjugated myc antibody (red) and visualized by 
microscope. Colocalization of ULK1 puncta and WIPI-1 puncta is shown in yellow color.  
Nuclei were stained with DAPI (blue). Scale bar,10 μm. 
(c) Higher magnification of images shown in (b). 
(d) Quantification of the colocalization of ULK1 puncta and WIPI-1 puncta. 
The numbers of ULK1 puncta and WIPI-1 puncta were counted in MCF2L2-silenced 
cells (n=18) or control cells (n=14).  Percentage of ULK1 punta that are overlapped by 
WIPI-1 puncta relative to total ULK1 puncta was compared. Two sample Student t-test 
was conducted to assess the significance of difference between MCF2L2-silenced cells 
and GFP shRNA-control cells. When p < 0.05, the difference is considered statisically 
significant.  
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III.      Potential function of MCF2L2 as a regulator of actin cytoskeleton 
a.         MCF2L2 has a partial GEF activity toward Rho small GTPases 
To further understand the function of MCF2L2 in the regulation of autophagy 
processes, I have examined the possibility that MCF2L2 might function as a GEF for Rho 
small GTPases as MCF2 and MCF2L do. To test this possibility, I have used the well-
established assay system that is based on monitoring the active state of Rho GTPases in 
cell lysate.  I transduced HEK293T cells with a plasmid encoding HA-MCF2L2 and 
analyzed the amounts of GTP-bound Rho GTPases (RhoA, Rac1, and CDC42) versus 
their total amounts using the assay kit from Millipore.  The active forms of the GTPases 
can specifically bind to the agarose beads with GST-tagged proteins containing the p21-
binding domain (PBD,  residues 67-150) of human p21-activated kinase-1 (PAK1).  This 
bound form could be monitored by antibodies specific to Rho GTPases.  I found that, 
compared to the control cells transduced by empty vector, cells transduced by MCF2L2-
encoding plasmid exhibited higher levels of GTP-bound forms of Rho GTPases (Figure 
14).  The total amounts of Rho GTPases remained constant. Although the difference was 
not dramatic, this result supports a possible role of MCF2L2 as a GEF toward the small 
GTPases. 
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Figure 14. MCF2L2 shows a partial activity of GEF toward Rho small GTPases. 
HEK293T cells were transfected with a plasmid encoding HA-MCF2L2 or empty 
vector as control. Forty-eight hrs after transfection, cell lysate was obtained and mixed 
with or without GTP or GDP.  GTP-bound forms of Cdc42, Rac1, and RhoA were pulled 
down using PAK1-PBD agarose beads. The GTP-bound forms of GTPases on the beads 
and the total amounts of Cdc42, Rac1, and RhoA in the cell lysate were analyzed by 
Western blotting using Rho-GTPase antibodies. 
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b.        MCF2L2 colocalizes with Arp3, a downstream effector of Rho GTPases. 
Since Rho small GTPases are known as an important regulator of actin nucleation 
(Etienne-Manneville and Hall, 2002), I tested whether MCF2L2 might have an effect on 
actin nucleation.  Actin nucleation is mediated by the Arp2/3 complex, which is regulated 
by Rho-GTPases (Liu et al., 2009b).  I first investigated whether Arp3 localization is 
affected by nutrient-starved conditions.  HeLa cells were transiently transduced by 
plasmids encoding GFP-Arp3 and cultured under Earle's Balanced Salt Solution (EBSS) 
medium for nutrient- and serum-starvation, the optimized condition to induce autophagy.  
GFP-Arp3 was monitored by microscope.  Under complete cell culture medium, GFP-
Arp3 was distributed throughout the cytoplasm (Figure 14).  In EBSS medium, GFP-
Arp3 formed puncta (Figure 15).  This result suggests that the actin nucleation factor is 
somehow regulated by nutrient conditions.  The GFP-Arp3 puncta colocalized with 
puncta of mCherry-MCF2L2 tht was coexpressed with GFP-Arp3 under EBSS (Figure 
15).  The colocalization of MCF2L2 puncta and Arp3 puncta implies that MCF2L2 may 
have an important role in Arp2/3-regulated actin polymerization. 
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Figure 15. MCF2L2 puncta co-localizes with Arp3 puncta. 
GFP-tagged Arp3 and mCherry-tagged MCF2L2 were expressed in HeLa cells. 
Cells were cultured under DMEM medium or EBSS starvation medium for 1 hr.  GFP-
Arp3 (green) and mCherry-MCF2L2 (red) were visualized by fluorescence microscope. 
Co-localization of Arp3 and MCF2L2 is shown in yellow color.  Nuclei were stained 
with DAPI (blue). Scale bar,10 μm. 
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IV.       MCF2L2 is important for the distribution of Atg9.  
An important step in autophagy process that is possibly dependent upon actin 
polymerization is the re-distribution of Atg9 (Monastyrska et al., 2008).  A study in yeast 
showed that Atg9 interacts with Arp2 during the trafficking of Atg9 between Golgi, 
endosome and the isolation membrane in autophagy (Monastyrska et al., 2008), implying 
that actin polymerization is involved in the trafficking of Atg9. The re-distribution has 
been proposed to be an important mechanism to provide membrane source for 
autophagosome (Sekito et al., 2009; Young et al., 2006). Studies in yeast and mammalian 
cells have shown that the trafficking of Atg9 may depend on the ULK1 complex 
(Reggiori et al., 2004; Young et al., 2006) and is likely regulated by the motor protein 
myosin and moves along actin filaments (Tang et al., 2010).  
Thus, I considered the possibility that MCF2L2 might regulate the cellular 
distribution of Atg9.  If MCF2L2 functions as a GEF for Rho GTPases and regulates 
Arp2/2 complex, MCF2L2 could affect Atg9 distribution by altering actin 
polymerization.  To test this possibility, I compared the pattern of Atg9 distribution 
between MCF2L2-silenced cells and GFP shRNA-transduced control cells.  To monitor 
the localization of Atg9, the shRNA-tranduced HeLa cells were transiently transduced by 
a plasmid encoding GFP-Atg9. Cells were incubated in either complete medium or EBSS 
starvation medium.  The GFP-Atg9 as well as the trans-golgi compartment, which was 
monitored by using anti-TGN46 antibody, were visualized by microscope. Consistent 
with previous studies (Young et al., 2006), Atg9 localized to regions around TGN in 
complete medium.  The TGN-localized Atg9 was re-distributed to a dispersed pattern in 
the cytoplasm in control cells under starvation.  By contrast, MCF2L2 knockdown 
suppressed the distribution to the dispersed pattern with a large portion of Atg9 being 
retained in regions around TGN even in the starved condition (Figure 16).  This result 
suggests that MCF2L2 is required for the distribution of Atg9 from TGN to cytoplasm 
during starvation. 
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Figure 16. MCF2L2 knockdown inhibited the distribution of Atg9 and retained  
Atg9 in the TGN under starvation. 
(a)         GFP-tagged Atg9 was expressed in MCF2L2-silenced HeLa cells and GFP 
shRNA-transduced control cells.  Twenty-four hrs after transfection, cells were incubated 
in full DMEM medium or starvation medium (EBSS) for 1 hr. Cells were stained with 
trans-golgi network 46 (TGN46) antibody conjugated with Alexa647 (red) and were 
visualized by fluorescence microscope.  Co-localization of Atg9 with the TGN is shown 
in yellow color. Nuclei were stained with DAPI (blue). Scale bar,10 μm. 
(b)-(d)   Additional images showing localization of Atg9 and TGN in EBSS-starved cells. 
Nuclei were stained with DAPI (blue). Scale bar,10 μm. 
 
 
 
 
 
 
 
 
 
 
 
 88 
 
CHAPTER 3. DISCUSSION 
My thesis work has led to the discovery of MCF2L2, a novel component of the 
ULK1 complex.  My work has demonstrated that MCF2L2 interacts directly with Atg13 
through its N-terminal region.  The study has also revealed that MCF2L2 is important 
for autophagosome formation and autophagy flux.  I have determined that MCF2L2 is 
required for WIPI-1 to localize to the isolation membrane, which is an important 
downstream event following the recruitment of the ULK1 complex and the Atg14L-
containing PI3KC3 complex to the isolation membrane (Itakura and Mizushima, 2010). 
In addition, I have determined that MCF2L2 is important for the trafficking of Atg9, a 
process that provides membrane source for autophagosome (Orsi et al., 2012; Webber 
and Tooze, 2010; Young et al., 2006).  My study has also provided supportive evidence 
that MCF2L2 might regulate actin polymerization. Consistent with the possible 
functions, previous studies have shown that Atg9 is tightly associated with Atg18, the 
yeast homolog of WIPI (Reggiori et al., 2004; Wang et al., 2001a) and the trafficking of 
Atg9 is regulated by motor proteins moving along actin filaments (Tang et al., 2010). 
Atg9 has also been proposed to participate in actin nucleation (Monastyrska et al., 
2008). My study however could not clarify what is the exact mechanism through which 
MCF2L2 regulates autophagy.  Nevertheless, this work has provided an important basis 
for the future study to elucidate the signaling pathway from the ULK1 complex to the 
autophagy induction process.   
 
I. The architecture of the ULK1 complex associated with MCF2L2. 
Among the major members in the ULK1 complex, FIP200 most likely serves as a 
scaffolding protein providing the platform for the ULK1 complex to assemble as a whole 
(Hara et al., 2008), but the function of Atg13 remains unknown. The binding of Atg13 to 
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the N-terminus of MCF2L2 implies that Atg13 may serve as a docking site for MCF2L2 
to land on the FIP200 platform. 
The C-terminal region of ULK1 may regulate the conformation and activity of 
ULK1 (Chan et al., 2009) on top of its function of mediating ULK-binding proteins 
(Chan et al., 2007; Gan and Guan, 2008). A study using a limited proteolytic analysis 
revealed that ULK1 C-terminal region appears to fold back with the N-terminal kinase 
domain to keep the protein in a “closed” conformation in a manner dependent upon 
autophosphorylation (Chan et al., 2009). A putative autophosphorylation site Ser1047 
was identified at near the C-terminus of ULK1 (Dorsey et al., 2009).  The proteins may 
bind to the C-terminal region of ULK1 directly (Atg13) or indirectly (MCF2L2) to have 
influence on the conformation and activity of ULK1. 
 
II. MCF2L2 might regulate autophagy through the actin cytoskeleton. 
Little is known about the mechanism by which WIPIs and Atg9 are translocated 
to the autophagy machinery.  Based on my study, I propose two pathways through which 
MCF2L2 regulates the localization of WIPIs and Atg9.  One pathway might involve 
MCF2L2 acting as a GEF for Rho small GTPases to facilitate the actin polymerization.  
The actin polymerization is required for Atg9-mediated autophagic membrane dynamics. 
An alternative pathway might involve MCF2L2 acting as a GEF to stimulate the 
movement of myosin along the actin filaments.  Myosin serves as a cargo carrier to 
transport Atg9 and WIPIs to the origin of the isolation membrane formation (Figure 17).   
In the first pathway, I propose that the GEF activity of MCF2L2 is important for 
actin polymerization. The cytoskeletons have been emerging to play an important role in 
the autophagy process (Monastyrska et al., 2009).  While there have been some studies 
published on microtubules and their role in the vesicle membrane fusion in autophagy 
(Fass et al., 2006; Orsi et al., 2010), little is known about actin cytoskeleton in autophagy.  
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An important line of evidence has been provided by a recent study with respect to the 
function of actin cytoskeleton in the autophagy process.  The local assembly of F-actin 
(the polymer form of actin) was found at the site of autophagosome-lysosome fusion (Lee 
et al., 2010b).  This finding suggests that the autophagic membrane fusion might depend 
on actin polymerization. Based on the finding that MCF2L2 potentially contains a GEF 
activity (Figure 14) that can stimulate the actin nucleation catalyzed by the Arp2/3 
complex, which appears to colocalize with MCF2L2 (Figure 15), I hypothesize that 
MCF2L2 might play an important role in the actin polymerization required for the 
formation of isolation membrane or for the fusion of autophagosomal membranes. 
Generation and expansion of the isolation membrane may require cytoskeletal re-
organization fueled by actin polymerization in the proximal region, and this may explain 
that MCF2L2 knockdown possibly interferes with isolation membrane generation, as 
suggested by the abolished  puncta formation of the isolation membrane marker WIPI-1 
(Figure 13).  
Another potential link of MCF2L2 to autophagy appears to be the regulation of 
Atg9 trafficking.  In yeast, Atg9 was shown to interact with Arp2 during its trafficking 
among the autophagosome membrane sources (Monastyrska et al., 2008).  Atg9 interacts 
dynamically with isolation membranes and autophagosomes but without being physically 
incorporated into the autophagosomal membranes (Orsi et al., 2012).  Therefore, Atg9 is 
thought to deliver membranes for the biogenesis of autophagosome.  The interaction 
between Atg9 and Arp2 probably indicates that the delivery of membranes by Atg9 might 
depend on active actin polymerization.  MCF2L2 may be responsible for the activation of 
the actin polymerization through its GEF activity. The knockdown of MCF2L2 interferes 
with Atg9 translocation may suggest that Atg9 is involved in actin polymerization. 
While the autophagic membrane dynamics may be coupled with actin 
polymerization within a local region, the protein factors required in the membrane 
biogenesis need to travel a longer distance in the cell.  WIPIs were found to translocate 
from the cytosol to neonascent isolation membrane when autophagy is induced (Itakura 
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and Mizushima, 2010; Polson et al., 2010).  In yeast, the WIPI homolog Atg18 was found 
to form a complex with Atg2 as an effector of PI3P (Obara et al., 2008). Atg18 also 
interacts with Atg9 in yeast to mediate membrane transportation (Reggiori et al., 2004; 
Wang et al., 2001a). The mammalian WIPIs are also effectors of PI3P (Polson et al., 
2010), while its interaction with Atg9 has not been reported and how WIPIs facilitate the 
isolation membrane formation remains clear.  Atg9 cycles between the TGN and the 
cytoplasma in autophagy (Young et al., 2006). Atg9 is thought to be a courier to deliver 
membrane sources for isolation membrane formation (Orsi et al., 2012; Young et al., 
2006). The transport of Atg9 in yeast is dependent on the Atg2-Atg18 complex (Reggiori 
et al., 2004; Wang et al., 2001a) and the Atg1-Atg13-Atg17 complex (Reggiori et al., 
2004; Sekito et al., 2009). In mammalian cells, whether Atg9 relocalization is dependent 
on ULK1 remains unclear (Orsi et al., 2012; Young et al., 2006).  According to my study, 
it is possible that MCF2L2 plays a role in mediating the ULK1 complex function in the 
regulation of Atg9 trafficking.  
 A recent study suggested that the translocation of Atg9 relies on the movement of 
myosin along the actin filaments (Tang et al., 2010).  Myosin is regulated by ROCK, a 
Rho-GTPase effector, and therefore it is subject to the regulation by Rho-GEF. A 
tentative model is that MCF2L2 activates RhoA and subsequently ROCK. The regulation 
of myosin by ROCK carries Atg9 along the actin filaments. This model is consistent with 
the result that MCF2L2 knockdown resulted in retaining of Atg9 on TGN in starvation 
induced autophagy (Figure 16).  I also observed that knockdown of MCF2L2 had little 
effect on ULK1 and Atg14 recruitment to isolation membrane but it blocks the 
recruitment of WIPI-1 to the isolation membrane (Figure 12 & 13). It is possible that 
MCF2L2 is required for PI3P to regulate WIPIs, or MCF2L2 can directly regulate the 
transport of WIPIs. There has not been any report showing a link between Rho GEF and 
WIPIs.  Given the physical interaction between Atg9 and Atg18 in yeast, MCF2L2 could 
also regulate WIPI translocation through the ROCK-myosin pathway. The yeast Atg2 
forms a complex with Atg18 and regulates Atg9 (Obara et al., 2008). Mammalian Atg2 
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has recently been identified (Velikkakath et al., 2012).  It would be interesting to 
investigate the possibility that the mammalian Atg2-WIPI complex is associated with 
Atg9.  
 
III .       A possible function of MCF2L2 in the formation of isolation membrane 
My study has revealed that ULK1 induces phosphorylation of MCF2L2 in cells 
and can directly phosphorylate MCF2L2 in vitro (Figure 11c).  Although these data are 
not sufficient to define MCF2L2 as a substrate of ULK1, it is highly likely that the 
MCF2L2 phosphorylation may be mediated by ULK1 given their interaction and 
functional connection.  Possibly, the phosphorylation of MCF2L2 by ULK1 might play 
an important role in the stimulation of the ULK1 complex in the formation of the 
isolation membrane. Whether MCF2L2 is a substrate of ULK1 needs further 
investigation such as identification of phosphorylation sites.  I attempted to identify 
phosphorylation sites by isolating MCF2L2 and analyzing it by mass spectrometry but 
failed to identify any phosphorylation sites. The reasons for the inability to identify 
phosphorylation sites include that the experiment may need to be optimized to enrich the 
phosphorylated protein and to increase the sensitivity of the mass spectrometry to identify 
the sites.  Due to these technical complications, I could not include this work in my thesis. 
At the initial stage of the autophagy process, ULK1 and Atg14L simultaneously 
gather in punctuate forms and locate to the isolation membrane (Itakura and Mizushima, 
2010; Matsunaga et al., 2009).  In mammalian cells, ULK1 is required for the formation 
of Atg14L puncta (Itakura and Mizushima, 2010). The formation of ULK1 puncta and 
Atg14L puncta is not blocked by wortmannin, the chemical inhibitor of PI3KC3.  This 
supports the model that the ULK1 complex acts upstream of the Atg14-containing 
PI3KC3 complex in autophagy induction.  In my study, the knockdown of MCF2L2 did 
not affect the puncta formation of ULK1 or Atg14L, indicating that MCF2L2 might not 
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be essential in ULK1-regulated PI3KC3 complex recruitment.   However, knocking down 
of MCF2L2 interfered with the aggregation of PI3P effector, WIPI-1, and other 
downstream events in autophagy, such as the conversion of LC3-I to LC-II, 
autophagosome formation, and p62 degradation.  These findings suggest that MCF2L2 
may function downstream of the recruitment of PI3KC3 complex.  The kinase-dead form 
of ULK1 is still recruited to the isolation membrane (Chan et al., 2007; Chan et al., 2009). 
Therefore, I speculate that MCF2L2 is recruited to the isolation membrane together with 
the ULK1 complex and the Atg14-PI3KC3 complex, and is subsequently phosphorylated 
by ULK1. Its GEF activity then regulates downstream events such as WIPI recruitment 
and autophagosome formation.  To demonstrate this proposed model, it is essential to test 
the MCF2L2 mutant where a key residue in the GEF domain is mutated.  
The function of MCF2L2 as a GEF toward small GTPases and actin 
polymerization regulator still remains ambiguous.  A possible link for the putative 
MCF2L2 function in autophagy induction might be related to the regulation of the 
Exocyst complex consisting of 8 subunits EXO1-8, formerly known as  Sec3, Sec5, Sec6, 
Sec8, Sec10, Sec15, Exo70, and Exo84 (Bodemann et al., 2011). Exocyst has been 
identified as a binding complex of  the ULK1 complex, providing important insight into 
the mechanism through which the ULK1 complex forms puncta tructure upon activation 
of autophagy and how it signals to the PI3KC3 complex (Bodemann et al., 2011).  
Nutrient deprivation activates Ras-like small GTPase RalB, which localizes to nascent 
autophagosomes, and RalB then activates its effector protein and Exocyst component 
Exo84 to promote autophagosome formation. The Exocyst complex was proposed to play 
a scaffolding role to allow for the interaction between ULK1 complex and the Beclin1-
VPS34 PI3KC3 complex (Bodemann et al., 2011). It is possible that  MCF2L2 regulates 
cytoskeleton rearrangement and thereby supports the scaffolding function of Exocyst.  
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Figure 17. Proposed models for the regulation of MCF2L2 on autophagy through 
the cytoskeleton. 
MCF2L2 was identified as a component of the ULK1 complex. It binds to Atg13 
via its N-terminal region and to the C-terminal region of ULK1 via Atg13 (Figure 10). 
ULK1 potentially phosphorylates MCF2L2 (Figure 11).  As part of the ULK1 complex, 
MCF2L2 is proposed to act as a GEF for Rho GTPases (Figure 14). The Rho GTPases 
activates Arp2/3 and actin polymerization.  MCF2L2 may participate in the isolation 
membrane formation through its stimulation of actin nucleation (Figure 15). MCF2L2 
may also exert its regulatory effects on the transport of Atg9 (Figure 16) and WIPI-1 
(Figure 13) through the ROCK-myosin pathway. 
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IV.      Summary 
The yeast two hybrid screen for Atg13 binding partners led to identification of 
MCF2L2 as a novel component of the ULK1 complex. MCF2L2 directly interacts with 
Atg13 through its N-terminal region.  MCF2L2 binds to the C-terminal region of ULK1 
via Atg13.  MCF2L2 plays an important role in the autophagosome formation and 
autophagy flux and it is a potential substrate of ULK1. MCF2L2 is not important for the 
formation of ULK1 puncta and Atg14L puncta but important for WIPI-1 recruitment to 
Atg14L puncta or the isolation membrane.  Thus, MCF2L2 appears to play a role in the 
regulation of the process downstream of the ULK1 complex and the Atg14L-PI3KC3 
complex.  MCF2L2 is proposed to be a GEF for Rho small GTPases and it colocalizes 
with actin nucleation factor Arp3, one of the targets of Rho GTPases. The role of 
MCF2L2 in the regulation of actin cytoskeleton may contribute to the autophagic 
membrane trafficking mediated by Atg9 through the ROCK-myosin pathway.  Although 
my study could not clarify the exact mechanisms by which MCF2L2 regulates autophagy 
induction, it provided the molecular basis for better understanding the mechanism for the 
recruitment of WIPIs and the trafficking of Atg9.   
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CHAPTER 4. PERSPECTIVES 
a. How the MCF2L2-containing ULK1 complex contributes to the formation of the 
isolation membrane. 
A fundamental but yet un-answered question in the field of autophagy is how 
the membrane source of autophagosome is recruited in response to the autophagy 
induction signals in a synchronized manner to generate the isolation membrane.  Both de 
novo biogenesis and preexisting organelles might contribute to the membrane source of 
autophagosome (Weidberg et al., 2011).  The multiple organelles include, including ER, 
mitochondria, Golgi and plasma membrane, have been proposed to provide membrane 
source to the formation of the isolation membrane.  The finding of MCF2L2 as a 
component in the ULK1 complex suggests two possible contributions of the MCF2L2-
containing ULK1 complex in the isolation membrane formation. MCF2L might regulate 
actin polymerization at the site of membrane biogenesis.  As a consequence, MCF2L2 
might facilitate the myosin movement on actin filaments to transport Atg9-containing 
membrane vesicles.  To clarify the mechanisms, we propose several studies for the future 
works.   
 First, it will be necessary to identify the phosphorylation sites of MCF2L2 that 
are mediated by ULK1. Whether the phosphorylation site lies in the Rho-GEF or PH 
domain may imply if ULK1 regulates the Rho-GEF activity of MCF2L2. Determining 
the functions of the phosphorylations is anticipated to greatly improve understanding the 
mechanism by which ULK1 regulates the formation of the isolation membrane.  Second, 
the function of MCF2L2 as a GEF toward small GTPases will need to be further clarified.  
I found that MCF2L2 has a moderate effect on the activation of Rho GTPases (Figure 
14).  Such a moderate effect might indicate that the tested small GTPases are not the in 
vivo substrates of MCF2L2.  Alternatively, MCF2L2 might have only a weak activity as a 
GEF and it might have non-GEF functions.  Sequence alignment between MCF2L2, 
MCF2L and MCF2 revealed that there is an insert of amino acids 772-794 between the 
DH domain and the PH domain only in MCF2L2 (Figure 8b).  The insert might affect the 
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activity of MCF2L2 or its specificity in recognition of substrates.   It will be interesting to 
test if deletion of the insert affects the activity of MCF2L2 in the autophagy pathway.  
With this regard, a recent study has identified Rac3, a closely related isoform of Rac1 and 
Rac2, as a negative regulator of autophagy (Zhu et al., 2011). It is possible that MCF2L2 
can specifically target Rac3 and regulate the activity of Rac3 negatively instead of 
positively.  If Rac3 is the mediator of MCF2L2 regulation on autophagy (Figure 14), it 
would also explain why MCF2L knockdown did not have effects on autophagy. Further 
studies are also needed to test if the GEF activity of MCF2L2 if regulated by the 
induction of autophagy. 
Third, the interaction of MCF2L2 and Arp2 will need to be further characterized 
through multiple alternative approaches.  My study has only provided the colocalization 
of MCF2L2 puncta and Arp2 puncta under starvation (Figure 15).  It will be interesting to 
investigate how their interaction is regulated by nutritional status through co-
iummunoprecipitation analysis.  Once this interaction is demonstrated through co-
immunoprecipitation, the binding sites on those proteins can be identified.  The 
identification of binding sites could lead us to explore further the functional significance 
of the interaction in the regulation of actin polymerization and thereby the formation of 
the isolation membrane. Fourth, it will be important to further clarify the exact 
mechanism by which MCF2L2 regulates the trafficking of Atg9-embedded membrane 
vesicle and the recruitments of WIPIs to the isolation membrane.  It would be worthwhile 
to test the Atg2-WIPI complex in interaction with Atg9 and how MCF2L2 contributes to 
the interaction during the formation of the isolation membrane. Lastly, the signaling 
pathway from the MCF2L2-containing ULK1 complex to the ROCK-myosin machinery 
might need to be explored, since it would provide a novel insight into the mechanism 
underlying the mobilization of the autophagy proteins required for isolation membrane 
formation. 
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b. How MCF2L2 links to obesity-related diseases could be understood in terms of its 
role in autophagy regulation. 
There have been three publications about MCF2L2, and all of the studies are 
population studies to identify genetic linkages of obesity and obesity-related diseases 
(Takeuchi et al., 2008; Zhang et al., 2010; Zheng et al., 2009a).  Takeuchi F et. al. 
reported three single nucleotide polymorphisms (SNPs) (rs35368790, rs35069869, and 
rs684846) in the non-coding region of MCF2L2 gene that are associated with a higher 
risk of type II diabetes in a group of Japanese population  (Takeuchi et al., 2008). Two of 
the SNPs were identified in introns and one of them was identified in the 3’ untranslated 
region. The three SNPs belong to different linkage disequilibrium groups, which contain 
multiple alleles that are associated at a higher frequency than would be expected from a 
random formation of haplotypes. This indicates that the 3 SNPs might not have been 
inherited together due to the linkage disequilibrium in this population. Another study by 
Zheng et al. 2009 revealed that the same 3 SNP variants in MCF2L2 are associated with 
higher risk of polycystic ovary syndrome (PCOS) in a group of Chinese population 
(Zheng et al., 2009a).  A third study by Zhang D et. al. 2010 reported that two of the 
above SNPs are in the intron region and one more coding variant are linked to risk of 
diabetic nephropathy in a group of  European decendants (Zhang et al., 2010). Obesity is 
a prevalent characteristic among the patients with diabetes and diabetic nephropathy, and 
a major portion of patients with PCOS develop insulin resistance. Therefore, these three 
diseases are  thought be obesity-related diseases. 
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Figure 18. Disease-associated SNPs in the MCF2L2 gene. 
4 SNPs in MCF2L2 gene (NCBI dbSNP) were reported to be associated to 
obesity-related diseases (Takeuchi et al., 2008; Zhang et al., 2010; Zheng et al., 2009a). 
A. rs35368790—SNP in intron (major/minor allele: T/C) 
B. rs35069869---SNP in intron (T/C) 
C. rs684846---SNP in 3’ untranslated region (C/T) 
D. rs7639705---Coding variant (T/G, leucine359/isoleucine)  
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The studies above provide supportive evidence that MCF2L2's functions might be 
linked to the metabolic disease status.  Knowing that MCF2L2 regulates autophagy, it is 
logical to speculate that the functional linkage of MCF2L2 to the metabolic diseases 
might be due to alteration of autophagy activity.  There are emerging opinions on how 
autophagy activity is altered in diabetes or how autophagy can affect the disease 
progression (Jung and Lee, 2010). As an example, autophagy was found to participate in 
adipogenesis (Singh et al., 2009b), which contributes to insulin insensitivity. Besides the 
link between autophagy and adipogenesis, there are more avenues that can link MCF2L2 
to diabetes. In pancreatic  islet cells, autophagy is thought to contribute to the secretion 
of insulin (Jung and Lee, 2010).  Ras homolog family member Q, a member of the Rho 
family that is also called TC10 or RASL7A, is involved in the GTPase-dependent re-
organization of cortical actin and induces translocation of intracellular vesicles containing 
glucose transporters upon insulin stimulation (Chiang et al., 2001).  
PCOS is the most frequently occurring female endocrine disorder, with 
manifestations including multicystic ovaries as a distinctive feature, as well as 
dysfunctional follicular maturation and ovulation, and hyperandrogenism. A large portion 
of the patients also display metabolic abnormalities such as obesity and hyperinsulinism, 
and these patients carry increased risk of type II diabetes and cardiovascular diseases too 
(Shannon and Wang, 2012). There is very little evidence directly connecting autophagy 
to the origin of PCOS, but given the close relation of PCOS with diabetic metabolic 
disorders, it is fair to speculate that autophagy is implicated in the PCOS disease 
progress. The other disease that is linked to MCF2L2 SNPs, diabetic nephropathy is a 
main complication of diabetes. Podocytes (a subtype of kidney epithelial cells) were 
found to have high activity of autophagy, and deletion of Atg5 in mouse podocytes 
resulted in accumulation of proteinuria and glomerulopathy (Hartleben et al., 2010).  This 
study suggests a protective role of autophagy against the metabolic stress in kidney cells.  
The consistent association of MCF2L2 with the metabolic diseases implies that 
certain pathways dependent on MCF2L2 may be important in the obesity-related 
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diseases.  Since MCF2L2 gene has not been identified in the mouse genome, it is 
impossible to study the role of MCF2L2 in the metabolic diseases using mouse models. 
Instead, it is feasible to investigate the role of autophagy in the obesity-related diseases in 
the future using mouse models targeting  key autophagy genes .  
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MATERIAL AND METHODS 
Materials 
Anti- ULK1 (sc-10900 and sc-33182), tubulin (sc-12462), GAPDH (sc-25778) 
and 14-3-3 (sc-732) antibodies were purchased from Santa Cruz Biotechnology (Santa 
Cruz, CA). Anti-p62 was purchased from BD Biosciences (no. 610832; San Jose, CA). 
Anti-hemagglutinin (HA) antibody (HA.11) was purchased from Covance (Berkeley, 
CA). Anti-Myc 9E10 mAb and rapamycin were purchased from EMD Biosciences (San 
Diego, CA). Anti-Atg13, ULK1, and MCF2L2 antibodies were generated by the Yenzym 
custom antibody service (South San Francisco, CA) from rabbits using glutathione S-
transferase (GST)-tagged C-terminal (amino acid 250-1129) of protein (MCF2L2) or 
epitope peptides CETDLNSQDRKDLDK-amide and CDLGTFYREFQNPPQ-amide 
(Atg13) and MEPGRGGTETVGKFEFSC-amide (ULK1) as antigens as previously 
reported (Jung et al., 2009).  Polyclonal anti-TGN-46 antibody was obtained from 
Serotec Inc. (Oxford, UK). ULK1-deficient MEFs were obtained from Dr. Kundu's group 
at St. Louis Children’s hospital (Kundu et al., 2008).  
Yeast two hybrid screen 
Yeast expressing pGBT9-bait were grown in trp- dropout media. Human fetal 
brain library DNA (clontech) was transformed via LiAc/PEG method into prepared yeast 
cells. Cells were plated in trp-/leu-/his-/3mM 3-AT plates and incubated at 30 deg. C 
approximately 7-10 days. Primary isolates were restreaked on trp-/leu-/his-/3mM 3AT 
plates and grown several days for lacZ assays. Positive colonies that showed a color 
change in LacZ assays were picked for colony PCR. Alternatively, DNA was isolated 
from yeast and transformed in to bacteria for miniprep analysis and sequencing. Plasmids 
containing Gal4AD-cDNA library clones were recovered by transforming DNA into E. 
coli MH4 cells ). Transformants were plated on M9 minimal medium lacking leucine but 
containing ampicillin. Plasmid DNA was isolated from bacteria and digested to confirm 
insert size. After sequencing, plasmid DNA was transformed into yeast strain AH109 in 
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combination with the original bait plasmid. Transformants were selected for growth on 
trp-/leu- plates, and streaked onto trp-/leu-/his-/3mM 3-AT plates to test for growth. 
DNA constructions  
Human MCF2L2 cDNAs were obtained from Katzusa Institute (KIAA08661, 
2914 NTs) and Open Biosystems (Huntsville, AL; Image no. 5750039, 2101 NTs) and 
the two cDNA fragments were joined to generate the full length gene. Human ULK1 and 
Atg13 cDNA clones were obtained from Katzusa Institute in Japan.  Human FIP200 
cDNA clone was obtained from Open Biosystems (Image no. 3908134). MCF2L2, ULK1 
and Atg13 fragments were obtained by PCR amplification and subcloned into HA- and 
myc-prk5 vector. The cDNAs for Atg9 and WIPI-1 were obtained from Open Biosystems.  
The GFP-Arp3 was kindly provided by Dr. Lorene Lanier in the Department of 
Neuroscience at the University of Minnesota. 
Protein purification 
The C-terminal fragments of MCF2L2 were expressed as GST-tagged forms in 
ArcticExpress bacterial cells (Stratagene, Agilent La Jolla, CA).  Bacteria were cultured 
in LB medium for 4 hrs and induced with 1 mM isopropyl-1-thio-b-galatopyranoside 
(IPTG) followed by incubation of 16 hrs at 15°C.  Bacteria were lysed in 50 mM HEPES 
(pH 7.5), 400 mM NaCl, 1 mM DTT, and 1 mM Phenyl-methyl-sulfonyl fluoride (PMSF) 
(Sigma Aldrich, St. Louis, MO).  Cell lysate was centrifuged at 10,000 × g for 30 mins. 
The soluble supernatant fraction was again centrifuged for 40 minutes at 4 °C at 100,000 
× g and the soluble extract was applied to a glutathione sepharose 4B column (GE 
Amersham, Piscataway, NJ).  The GSH column retaining the bound proteins was washed 
with buffer (20 mM HEPES (pH 7.5), 300 mM NaCl, 1mM MgCl2, 1 mM DTT). GST-
tagged proteins were treated with PreScission protease (GE Amersham, Piscataway, NJ) 
overnight at 4°C. The eluate, which contains GST-free proteins, was applied to SDS-
PAGE and stained with Coomassie blue to determine the purity of proteins.  The eluted 
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proteins were dialyzed against 20 mM HEPES (pH 7.5), 300 mM NaCl, 1mM MgCl2, 1 
mM DTT to remove GSH and snap frozen in liquid nitrogen. 
Cell culture and transfection  
HEK293T, HeLa, and MEF cells were cultured in DMEM containing 10% of fetal 
bovine serum and 5% of penicillin/streptomycin at 37°C in 5% CO2. For transient 
expression of proteins, cells were transfected with recombinant DNAs or short hairpin 
RNA (shRNA) plasmids using FuGENE 6 (Roche Applied Science, Indianapolis, IN) 
following the manufacturer's protocol.  Cells were harvested 2d after transfection for 
coimmunoprecipitation assay or other biochemical or Western blot analysis. 
Co-immunoprecipitation and Western Blotting  
Whole cell extracts were prepared in a lysis buffer containing 0.3% Chaps or 1% 
Triton X-100 as described previously (Jung et al., 2009) and immunoprecipitated with 
antibodies described for each experiment. Precipitated proteins were washed four times 
with the lysis buffer, loaded onto 8%  or 12% Tris-glycine gels, transferred onto 
polyvinylidene difluoride membranes (Bio-Rad, Richmond, CA), and detected with 
enhanced chemiluminescence Western blotting detection reagents (Perkin Elmer-Cetus, 
Norwalk, CT). 
Lentiviral preparation and viral infection  
Lentiviral shRNA transduction was performed as described previously (Jung et 
al., 2009). Briefly, the pLKO shRNA vectors encoding shRNAs were transfected into 
HEK293T with lentiviral packaging vectors pHR'8.2ΔR and pCMV-VSV-G using 
FuGENE 6.  Viruses were collected 60 h after transfection.  Target cells, such as 
HEK293T, HeLa, or MEF cells, were infected with the collected viruses for 4 h in the 
presence of polybrene.  Lentiviral sh-RNA target sequences are 5’-
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aacgtacgcggaatacttcga-3’, 5’-gaatttggagctggaggat-3’ and 5'-ccaggaaacttacagctca-3' for 
control, Atg13 and MCF2L2, respectively. 
Western blot assay of autophagy flux and p62 level 
The lentiviral shRNA-transduced HEK293T cells were treated with rapamycin or 
vehicle for 4 h in the presence or absence of pepstatin A (10 μg/ml) and E-64 (10 μg/ml), 
inhibitors of the lysosomal protein degradation (Sigma). Whole cell extracts were 
prepared in lysis buffer containing 1% Triton X-100. Cell lysates were run on SDS-
PAGE, and proteins were transferred to PVDF membranes and probed with anti-LC3 
mouse polyclonal antibody (Nanotools) and anti-p62 antibody (Bethyl Laboratories). 
GST pull-down assay 
The DNA constructs for GST-tagged MCF2L2N-terminal fragments (1-500 and 
1-827) were cloned in the plasmid pGEX-6P-2 (Amersham Biosciences, Piscataway, NJ) 
and introduced into in ArcticExpress bacterial cells (Stratagene, Agilent La Jolla, CA). 
The GST fusion proteins were expressed by induction with 0.1 mM IPTG for 16 h.  
Bacteria were resuspended into a lysis buffer (50 mM Tris, pH 8, 100 mM NaCl, 1 mM 
DTT) containing 1 mg/ml lysozyme, and cells were sonicated on ice. Soluble fractions 
were collected and immobilized on 100 μl of glutathione-Sepharose 4B beads 
(Amersham Biosciences). GST alone or GST-tagged MCF2L2 N-terminal fragments 
were incubated with bacterial–purified Atg13 for 1 h at 4 °C. After washing the beads, 
the bound proteins were eluted by boiling samples for 10 min in the presence of 
electrophoresis loading buffer, and the amounts of Atg13 recovered with GST-tagged 
proteins were we analyzed by Western blotting. 
In vitro kinase assay  
For ULK kinase assay, myc-tagged ULK1 were isolated by immunoprecipitation 
using anti-myc antibody (Calbiochem, OP10) from HEK293T cells. As substrates, 
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MCF2L2 (1-500 and 1-827) were purified from bacteria as described above. The kinase 
reaction was performed in a buffer containing 50 mM HEPES, pH 7.5, 1 mM EGTA, 
0.01% Tween 20, 10 mM MnCl2, 2.5 mM DTT, 100 μM ATP, 1 μg substrate, and the 
trace [γ-32P]ATP for 30 and 60 min at 30°C. All the kinase reactions were stopped by 
adding 5× SDS-sample loading buffer.  
Microscopic analysis of autophagosome formation 
The lentiviral shRNA-transduced HeLa cells were seeded onto glass coverslips. 
Medium was refreshed with DMEM containing 10% fetal bovine serum after 24h, and 
autophagy was induced by 100 nM rapamycin or vehicle (DMSO) for 4 h in the presence 
of pepstatin (10 μg/ml) after an additional 24 h. Cells were fixed with formaldehyde, 
permeabilized using methanol and 1% Triton X-100, and stained with 4, 6-
diamidinophenylindole (DAPI) and anti-LC3 antibody (Nanotools). Stained cells were 
visualized under Deltavision deconcolution microcope using 40X lense (Applied 
Precision, Inc. Issaquah, Washington). For visualization of MCF2L2, Arp3, WIPI, Atg9, 
and TGN-46, the corresponding GFP- or Cherry- constructs were transfected in the cell. 
Alexa fluorescent signal conjugated secondary antibodies were used to stain endogenous 
proteins. 
Rho small GTPase activation assay 
HEK293T cells were transfected with empty vector or a plasmid encoding HA-
tagged MCF2L2.  Cell lysates were collected and 500 µg of protein was used for the Rho 
small GTPase activity assay (Millipore, Rac1/Cdc42 activation kit cat# 17-441; RhoA 
activation kit cat# 17-294).  GTP and GDP were added to the lysates as positive and 
negative controls.  The agarose beads retaining GST tagged PBD (p21-binding domain 
containing residues 67-150 of human p21 PAK1)  were used to selectively precipitate the 
active (GTP-bound) form of the Rho small GTPases.  The precipitated small GTPase was 
then detected by Western blot using antibodies to Rho GTPases.included in the kit. 
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Statistical analysis 
In the comparison of percentage of ULK1 punta overlapped by WIPI-1 puncta in 
MCF2L2-silenced cells vs. GFP control cells, Student t-test was used to detect the 
significance of difference. No outliers were excluded. P<0.05 was used to define 
statistical significance. 
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